☒
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
☐
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Delaware
|
|
|
63-1261433
|
||||||
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
|
(IRS Employer Identification No.)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
100 Brookwood Place,
|
Birmingham,
|
AL
|
|
|
|
|
|
35209
|
(Address of Principal Executive Offices)
|
|
|
(Zip Code)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
(205)
|
877-4400
|
|
|
|
||||
(Registrant’s Telephone Number,
Including Area Code)
|
|
|
(Former Name, Former Address, and Former
Fiscal Year, if Changed Since Last Report)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.01 per share
|
PRA
|
New York Stock Exchange
|
Large accelerated filer
|
|
☒
|
|
|
Accelerated filer
|
|
☐
|
Non-accelerated filer
|
|
☐
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
☐
|
Emerging growth company
|
|
☐
|
|
|
|
|
|
Term
|
Meaning
|
AAD
|
Annual aggregate deductible
|
AOCI
|
Accumulated other comprehensive income (loss)
|
ASU
|
Accounting Standards Update
|
BEAT
|
Base erosion anti-abuse tax
|
Board
|
Board of Directors of ProAssurance Corporation
|
BOLI
|
Business owned life insurance
|
Council of Lloyd's
|
The governing body for Lloyd's of London
|
CODM
|
Chief Operating Decision Maker
|
Commutation
|
An agreement between a ceding insurer and the reinsurer that provides for the valuation, payment, and complete discharge of all obligations between the parties under a particular reinsurance contract
|
DDR
|
Death, disability and retirement
|
DPAC
|
Deferred policy acquisition costs
|
Eastern Re
|
Eastern Re, LTD, S.P.C.
|
EBUB
|
Earned but unbilled premium
|
E&O
|
Errors and Omissions
|
FAL
|
Funds at Lloyd's
|
FASB
|
Financial Accounting Standards Board
|
FHLB
|
Federal Home Loan Bank
|
FHLMC
|
Federal Home Loan Mortgage Corporation
|
FNMA
|
Federal National Mortgage Association
|
GAAP
|
Generally accepted accounting principles in the United States of America
|
GILTI
|
Global intangible low-taxed income
|
GNMA
|
Government National Mortgage Association
|
HCPL
|
Healthcare professional liability
|
IBNR
|
Incurred but not reported
|
Inova Re
|
Inova Re, LTD, S.P.C.
|
IRS
|
Internal Revenue Service
|
LIBOR
|
London Interbank Offered Rate
|
LLC
|
Limited liability company
|
Lloyd's
|
Lloyd's of London market
|
LP
|
Limited partnership
|
LPT
|
Loss portfolio transfer
|
Medical technology liability
|
Medical technology and life sciences products liability
|
Mortgage Loans
|
Two ten-year mortgage loans collectively with an original borrowing amount of approximately $40 million, each entered into by a subsidiary of ProAssurance
|
NAIC
|
National Association of Insurance Commissioners
|
NAV
|
Net asset value
|
NOL
|
Net operating loss
|
NRSRO
|
Nationally recognized statistical rating organization
|
NYSE
|
New York Stock Exchange
|
OCI
|
Other comprehensive income (loss)
|
OTTI
|
Other-than-temporary impairment
|
PCAOB
|
Public Company Accounting Oversight Board
|
Term
|
Meaning
|
Revolving Credit Agreement
|
ProAssurance's $250 million revolving credit agreement
|
ROE
|
Return on equity
|
ROU
|
Right-of-use
|
SAP
|
Statutory accounting principles
|
SEC
|
Securities and Exchange Commission
|
SPA
|
Special Purpose Arrangement
|
SPC
|
Segregated portfolio cell
|
Specialty P&C
|
Specialty Property and Casualty
|
Syndicate 1729
|
Lloyd's of London Syndicate 1729
|
Syndicate 6131
|
Lloyd's of London Syndicate 6131, a Special Purpose Arrangement with Lloyd's of London Syndicate 1729
|
Syndicate Credit Agreement
|
Unconditional revolving credit agreement with the Premium Trust Fund of Syndicate 1729
|
TCJA
|
Tax Cuts and Jobs Act H.R.1 of 2017
|
U.K.
|
United Kingdom of Great Britain and Northern Ireland
|
ULAE
|
Unallocated loss adjustment expense
|
VIE
|
Variable interest entity
|
|
changes in general economic conditions, including the impact of inflation or deflation and unemployment;
|
|
our ability to maintain our dividend payments;
|
|
regulatory, legislative and judicial actions or decisions that could affect our business plans or operations, including the impact of Brexit;
|
|
the enactment or repeal of tort reforms;
|
|
formation or dissolution of state-sponsored insurance entities providing coverages now offered by ProAssurance which could remove or add sizable numbers of insureds from or to the private insurance market;
|
|
changes in the interest and tax rate environment;
|
|
resolution of uncertain tax matters and changes in tax laws, including the impact of the TCJA;
|
|
changes in laws or government regulations regarding financial markets or market activity that may affect our business;
|
|
changes in the ability of the U.S. government to meet its obligations that may affect the U.S. economy and our business;
|
|
performance of financial markets affecting the fair value of our investments or making it difficult to determine the value of our investments;
|
|
changes in requirements or accounting policies and practices that may be adopted by our regulatory agencies, the FASB, the SEC, the PCAOB or the NYSE that may affect our business;
|
|
changes in laws or government regulations affecting the financial services industry, the property and casualty insurance industry or particular insurance lines underwritten by our subsidiaries;
|
|
the effect on our insureds, particularly the insurance needs of our insureds, and our loss costs, of changes in the healthcare delivery system and/or changes in the U.S. political climate that may affect healthcare policy or our business;
|
|
consolidation of our insureds into or under larger entities which may be insured by competitors, or may not have a risk profile that meets our underwriting criteria or which may not use external providers for insuring or otherwise managing substantial portions of their liability risk;
|
|
uncertainties inherent in the estimate of our loss and loss adjustment expense reserve and reinsurance recoverable;
|
|
changes in the availability, cost, quality or collectability of insurance/reinsurance;
|
|
the results of litigation, including pre- or post-trial motions, trials and/or appeals we undertake;
|
|
effects on our claims costs from mass tort litigation that are different from that anticipated by us;
|
|
allegations of bad faith which may arise from our handling of any particular claim, including failure to settle;
|
|
loss or consolidation of independent agents, agencies, brokers or brokerage firms;
|
|
changes in our organization, compensation and benefit plans;
|
|
changes in the business or competitive environment may limit the effectiveness of our business strategy and impact our revenues;
|
|
our ability to retain and recruit senior management;
|
|
the availability, integrity and security of our technology infrastructure or that of our third-party providers of technology infrastructure, including any susceptibility to cyber-attacks which might result in a loss of information or operating capability;
|
|
the impact of a catastrophic event, as it relates to both our operations and our insured risks;
|
|
the impact of acts of terrorism and acts of war;
|
|
the effects of terrorism-related insurance legislation and laws;
|
|
guaranty funds and other state assessments;
|
|
our ability to achieve continued growth through expansion into new markets or through acquisitions or business combinations;
|
|
changes to the ratings assigned by rating agencies to our insurance subsidiaries, individually or as a group;
|
|
provisions in our charter documents, Delaware law and state insurance laws may impede attempts to replace or remove management or may impede a takeover;
|
|
state insurance restrictions may prohibit assets held by our insurance subsidiaries, including cash and investment securities, from being used for general corporate purposes;
|
|
taxing authorities can take exception to our tax positions and cause us to incur significant amounts of legal and accounting costs and, if our defense is not successful, additional tax costs, including interest and penalties; and
|
|
expected benefits from completed and proposed acquisitions may not be achieved or may be delayed longer than expected due to business disruption; loss of customers, employees or key agents; increased operating costs or inability to achieve cost savings; and assumption of greater than expected liabilities, among other reasons.
|
Additional risks, assumptions and uncertainties that could arise from our membership in the Lloyd's market and our participation in Lloyd's Syndicates include, but are not limited to, the following:
|
|
|
members of Lloyd's are subject to levies by the Council of Lloyd's based on a percentage of the member's underwriting capacity, currently a maximum of 3%, but can be increased by Lloyd's;
|
|
Syndicate operating results can be affected by decisions made by the Council of Lloyd's which the management of Syndicate 1729 and Syndicate 6131 have little ability to control, such as a decision to not approve the business plan of Syndicate 1729 or Syndicate 6131, or a decision to increase the capital required to continue operations, and by our obligation to pay levies to Lloyd's;
|
|
Lloyd's insurance and reinsurance relationships and distribution channels could be disrupted or Lloyd's trading licenses could be revoked, making it more difficult for a Lloyd's Syndicate to distribute and market its products;
|
|
rating agencies could downgrade their ratings of Lloyd's as a whole; and
|
|
Syndicate 1729 and Syndicate 6131 operations are dependent on a small, specialized management team and the loss of their services could adversely affect the Syndicate’s business. The inability to identify, hire and retain other highly qualified personnel in the future could adversely affect the quality and profitability of Syndicate 1729’s or Syndicate 6131's business.
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
||
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
June 30,
2019 |
|
December 31,
2018 |
||||
Assets
|
|
|
|
||||
Investments
|
|
|
|
||||
Fixed maturities, available for sale, at fair value; amortized cost, $2,188,547 and $2,116,825, respectively
|
$
|
2,229,346
|
|
|
$
|
2,093,798
|
|
Fixed maturities, trading, at fair value; cost, $42,905 and $38,445, respectively
|
43,156
|
|
|
38,188
|
|
||
Equity investments, at fair value; cost, $398,489 and $450,931, respectively
|
420,425
|
|
|
442,937
|
|
||
Short-term investments
|
287,009
|
|
|
308,319
|
|
||
Business owned life insurance
|
65,008
|
|
|
64,096
|
|
||
Investment in unconsolidated subsidiaries
|
385,631
|
|
|
367,757
|
|
||
Other investments, $33,824 and $31,344 at fair value, respectively, otherwise at cost or amortized cost
|
36,725
|
|
|
34,287
|
|
||
Total Investments
|
3,467,300
|
|
|
3,349,382
|
|
||
Cash and cash equivalents
|
91,879
|
|
|
80,471
|
|
||
Premiums receivable
|
278,828
|
|
|
261,466
|
|
||
Receivable from reinsurers on paid losses and loss adjustment expenses
|
17,418
|
|
|
11,558
|
|
||
Receivable from reinsurers on unpaid losses and loss adjustment expenses
|
352,012
|
|
|
343,820
|
|
||
Prepaid reinsurance premiums
|
48,392
|
|
|
40,631
|
|
||
Deferred policy acquisition costs
|
55,871
|
|
|
54,116
|
|
||
Deferred tax asset, net
|
11,290
|
|
|
29,108
|
|
||
Real estate, net
|
30,841
|
|
|
31,114
|
|
||
Operating lease ROU assets
|
20,374
|
|
|
—
|
|
||
Intangible assets, net
|
73,815
|
|
|
76,776
|
|
||
Goodwill
|
210,725
|
|
|
210,725
|
|
||
Other assets
|
127,373
|
|
|
111,559
|
|
||
Total Assets
|
$
|
4,786,118
|
|
|
$
|
4,600,726
|
|
Liabilities and Shareholders' Equity
|
|
|
|
||||
Liabilities
|
|
|
|
||||
Policy liabilities and accruals
|
|
|
|
||||
Reserve for losses and loss adjustment expenses
|
$
|
2,195,460
|
|
|
$
|
2,119,847
|
|
Unearned premiums
|
441,923
|
|
|
415,211
|
|
||
Reinsurance premiums payable
|
54,891
|
|
|
55,614
|
|
||
Total Policy Liabilities
|
2,692,274
|
|
|
2,590,672
|
|
||
Operating lease liabilities
|
21,131
|
|
|
—
|
|
||
Other liabilities
|
203,940
|
|
|
199,295
|
|
||
Debt less debt issuance costs
|
287,217
|
|
|
287,757
|
|
||
Total Liabilities
|
3,204,562
|
|
|
3,077,724
|
|
||
Shareholders' Equity
|
|
|
|
||||
Common shares, par value $0.01 per share, 100,000,000 shares authorized, 63,112,288 and 62,989,421 shares issued, respectively
|
631
|
|
|
630
|
|
||
Additional paid-in capital
|
385,200
|
|
|
384,713
|
|
||
Accumulated other comprehensive income (loss), net of deferred tax expense (benefit) of $8,627 and ($4,355), respectively
|
31,729
|
|
|
(16,911
|
)
|
||
Retained earnings
|
1,581,273
|
|
|
1,571,847
|
|
||
Treasury shares, at cost, 9,352,373 shares as of each respective period end
|
(417,277
|
)
|
|
(417,277
|
)
|
||
Total Shareholders' Equity
|
1,581,556
|
|
|
1,523,002
|
|
||
Total Liabilities and Shareholders' Equity
|
$
|
4,786,118
|
|
|
$
|
4,600,726
|
|
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
Balance at April 1, 2019
|
|
$
|
631
|
|
|
$
|
383,494
|
|
|
$
|
8,655
|
|
|
$
|
1,586,393
|
|
|
$
|
(417,277
|
)
|
|
$
|
1,561,896
|
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
|
—
|
|
|
636
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
636
|
|
||||||
Share-based compensation
|
|
—
|
|
|
1,083
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,083
|
|
||||||
Net effect of restricted and performance shares issued
|
|
—
|
|
|
(13
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
||||||
Dividends to shareholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,656
|
)
|
|
—
|
|
|
(16,656
|
)
|
||||||
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
23,074
|
|
|
—
|
|
|
—
|
|
|
23,074
|
|
||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,536
|
|
|
—
|
|
|
11,536
|
|
||||||
Balance at June 30, 2019
|
|
$
|
631
|
|
|
$
|
385,200
|
|
|
$
|
31,729
|
|
|
$
|
1,581,273
|
|
|
$
|
(417,277
|
)
|
|
$
|
1,581,556
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
Balance at December 31, 2018
|
|
$
|
630
|
|
|
$
|
384,713
|
|
|
$
|
(16,911
|
)
|
|
$
|
1,571,847
|
|
|
$
|
(417,277
|
)
|
|
$
|
1,523,002
|
|
Cumulative-effect adjustment-
ASU 2018-07 adoption* |
|
—
|
|
|
—
|
|
|
—
|
|
|
(444
|
)
|
|
—
|
|
|
(444
|
)
|
||||||
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
|
—
|
|
|
812
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
812
|
|
||||||
Share-based compensation
|
|
—
|
|
|
2,320
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,320
|
|
||||||
Net effect of restricted and performance shares issued
|
|
1
|
|
|
(2,645
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,644
|
)
|
||||||
Dividends to shareholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(33,316
|
)
|
|
—
|
|
|
(33,316
|
)
|
||||||
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
48,640
|
|
|
—
|
|
|
—
|
|
|
48,640
|
|
||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
43,186
|
|
|
—
|
|
|
43,186
|
|
||||||
Balance at June 30, 2019
|
|
$
|
631
|
|
|
$
|
385,200
|
|
|
$
|
31,729
|
|
|
$
|
1,581,273
|
|
|
$
|
(417,277
|
)
|
|
$
|
1,581,556
|
|
* See Note 1 for discussion of accounting guidance adopted during the period.
|
||||||||||||||||||||||||
Continued on the following page.
|
Continued from the previous page.
|
||||||||||||||||||||||||
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
Balance at April 1, 2018
|
|
$
|
630
|
|
|
$
|
380,250
|
|
|
$
|
(8,046
|
)
|
|
$
|
1,614,344
|
|
|
$
|
(418,009
|
)
|
|
$
|
1,569,169
|
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
|
—
|
|
|
1,194
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,194
|
|
||||||
Share-based compensation
|
|
—
|
|
|
1,577
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,577
|
|
||||||
Net effect of restricted and performance shares issued
|
|
—
|
|
|
(20
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(20
|
)
|
||||||
Dividends to shareholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(17,630
|
)
|
|
—
|
|
|
(17,630
|
)
|
||||||
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
(8,097
|
)
|
|
—
|
|
|
—
|
|
|
(8,097
|
)
|
||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
28,423
|
|
|
—
|
|
|
28,423
|
|
||||||
Balance at June 30, 2018
|
|
$
|
630
|
|
|
$
|
383,001
|
|
|
$
|
(16,143
|
)
|
|
$
|
1,625,137
|
|
|
$
|
(418,009
|
)
|
|
$
|
1,574,616
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
Balance at December 31, 2017
|
|
$
|
628
|
|
|
$
|
383,077
|
|
|
$
|
14,911
|
|
|
$
|
1,614,186
|
|
|
$
|
(418,007
|
)
|
|
$
|
1,594,795
|
|
Cumulative-effect adjustment-
ASU 2016-01 adoption |
|
—
|
|
|
—
|
|
|
—
|
|
|
8,334
|
|
|
—
|
|
|
8,334
|
|
||||||
Cumulative-effect adjustment-
ASU 2018-02 adoption |
|
—
|
|
|
—
|
|
|
3,416
|
|
|
(3,416
|
)
|
|
—
|
|
|
—
|
|
||||||
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
|
—
|
|
|
1,316
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
1,314
|
|
||||||
Share-based compensation
|
|
—
|
|
|
2,479
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,479
|
|
||||||
Net effect of restricted and performance shares issued
|
|
2
|
|
|
(3,871
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,869
|
)
|
||||||
Dividends to shareholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(34,246
|
)
|
|
—
|
|
|
(34,246
|
)
|
||||||
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
(34,470
|
)
|
|
—
|
|
|
—
|
|
|
(34,470
|
)
|
||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
40,279
|
|
|
—
|
|
|
40,279
|
|
||||||
Balance at June 30, 2018
|
|
$
|
630
|
|
|
$
|
383,001
|
|
|
$
|
(16,143
|
)
|
|
$
|
1,625,137
|
|
|
$
|
(418,009
|
)
|
|
$
|
1,574,616
|
|
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Revenues
|
|
|
|
|
|
|
|
||||||||
Net premiums earned
|
$
|
209,149
|
|
|
$
|
223,591
|
|
|
$
|
417,298
|
|
|
$
|
410,750
|
|
Net investment income
|
23,539
|
|
|
22,384
|
|
|
46,357
|
|
|
44,411
|
|
||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
(5,152
|
)
|
|
5,380
|
|
|
(5,962
|
)
|
|
7,019
|
|
||||
Net realized investment gains (losses):
|
|
|
|
|
|
|
|
||||||||
OTTI losses
|
—
|
|
|
(404
|
)
|
|
(136
|
)
|
|
(404
|
)
|
||||
Portion of OTTI losses recognized in other comprehensive income before taxes
|
—
|
|
|
—
|
|
|
87
|
|
|
—
|
|
||||
Net impairment losses recognized in earnings
|
—
|
|
|
(404
|
)
|
|
(49
|
)
|
|
(404
|
)
|
||||
Other net realized investment gains (losses)
|
9,308
|
|
|
3,199
|
|
|
45,980
|
|
|
(9,318
|
)
|
||||
Total net realized investment gains (losses)
|
9,308
|
|
|
2,795
|
|
|
45,931
|
|
|
(9,722
|
)
|
||||
Other income
|
2,777
|
|
|
2,044
|
|
|
4,872
|
|
|
4,767
|
|
||||
Total revenues
|
239,621
|
|
|
256,194
|
|
|
508,496
|
|
|
457,225
|
|
||||
Expenses
|
|
|
|
|
|
|
|
||||||||
Net losses and loss adjustment expenses
|
168,440
|
|
|
161,728
|
|
|
328,195
|
|
|
291,515
|
|
||||
Underwriting, policy acquisition and operating expenses
|
|
|
|
|
|
|
|
||||||||
Operating expense
|
34,661
|
|
|
33,958
|
|
|
67,951
|
|
|
66,422
|
|
||||
DPAC amortization
|
28,047
|
|
|
25,653
|
|
|
56,149
|
|
|
50,547
|
|
||||
Segregated portfolio cells dividend expense (income)
|
(7,033
|
)
|
|
2,785
|
|
|
(2,246
|
)
|
|
4,532
|
|
||||
Interest expense
|
4,247
|
|
|
3,958
|
|
|
8,576
|
|
|
7,663
|
|
||||
Total expenses
|
228,362
|
|
|
228,082
|
|
|
458,625
|
|
|
420,679
|
|
||||
Income before income taxes
|
11,259
|
|
|
28,112
|
|
|
49,871
|
|
|
36,546
|
|
||||
Provision for income taxes
|
|
|
|
|
|
|
|
||||||||
Current expense (benefit)
|
1,507
|
|
|
(1,175
|
)
|
|
1,851
|
|
|
(2,503
|
)
|
||||
Deferred expense (benefit)
|
(1,784
|
)
|
|
864
|
|
|
4,834
|
|
|
(1,230
|
)
|
||||
Total income tax expense (benefit)
|
(277
|
)
|
|
(311
|
)
|
|
6,685
|
|
|
(3,733
|
)
|
||||
Net income
|
11,536
|
|
|
28,423
|
|
|
43,186
|
|
|
40,279
|
|
||||
Other comprehensive income (loss), after tax, net of reclassification adjustments
|
23,074
|
|
|
(8,097
|
)
|
|
48,640
|
|
|
(34,470
|
)
|
||||
Comprehensive income (loss)
|
$
|
34,610
|
|
|
$
|
20,326
|
|
|
$
|
91,826
|
|
|
$
|
5,809
|
|
Earnings per share
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
0.21
|
|
|
$
|
0.53
|
|
|
$
|
0.80
|
|
|
$
|
0.75
|
|
Diluted
|
$
|
0.21
|
|
|
$
|
0.53
|
|
|
$
|
0.80
|
|
|
$
|
0.75
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
|
|
||||||||
Basic
|
53,750
|
|
|
53,610
|
|
|
53,716
|
|
|
53,567
|
|
||||
Diluted
|
53,828
|
|
|
53,741
|
|
|
53,818
|
|
|
53,716
|
|
||||
Cash dividends declared per common share
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.62
|
|
|
$
|
0.62
|
|
|
Six Months Ended June 30
|
||||||
|
2019
|
|
2018
|
||||
Operating Activities
|
|
|
|
||||
Net income
|
$
|
43,186
|
|
|
$
|
40,279
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization, net of accretion
|
9,653
|
|
|
11,036
|
|
||
(Increase) decrease in cash surrender value of BOLI
|
(912
|
)
|
|
(904
|
)
|
||
Net realized investment (gains) losses
|
(45,931
|
)
|
|
9,722
|
|
||
Share-based compensation
|
2,320
|
|
|
2,517
|
|
||
Deferred income tax expense (benefit)
|
4,834
|
|
|
(1,230
|
)
|
||
Policy acquisition costs, net of amortization (net deferral)
|
(1,755
|
)
|
|
(1,932
|
)
|
||
Equity in (earnings) loss of unconsolidated subsidiaries
|
5,962
|
|
|
(7,019
|
)
|
||
Distributed earnings from unconsolidated subsidiaries
|
7,298
|
|
|
4,595
|
|
||
Other
|
1,643
|
|
|
796
|
|
||
Other changes in assets and liabilities:
|
|
|
|
||||
Premiums receivable
|
(17,362
|
)
|
|
(41,560
|
)
|
||
Reinsurance related assets and liabilities
|
(22,536
|
)
|
|
11,980
|
|
||
Other assets
|
(2,557
|
)
|
|
969
|
|
||
Reserve for losses and loss adjustment expenses
|
75,613
|
|
|
30,436
|
|
||
Unearned premiums
|
26,712
|
|
|
22,181
|
|
||
Other liabilities
|
(7,153
|
)
|
|
(16,300
|
)
|
||
Net cash provided (used) by operating activities
|
79,015
|
|
|
65,566
|
|
||
Investing Activities
|
|
|
|
||||
Purchases of:
|
|
|
|
||||
Fixed maturities, available for sale
|
(350,937
|
)
|
|
(552,451
|
)
|
||
Fixed maturities, trading
|
(4,486
|
)
|
|
(29,999
|
)
|
||
Equity investments
|
(38,959
|
)
|
|
(91,054
|
)
|
||
Other investments
|
(13,769
|
)
|
|
(15,228
|
)
|
||
Funding of qualified affordable housing project tax credit partnerships
|
(322
|
)
|
|
(74
|
)
|
||
Investment in unconsolidated subsidiaries
|
(41,947
|
)
|
|
(27,734
|
)
|
||
Proceeds from sales or maturities of:
|
|
|
|
||||
Fixed maturities, available for sale
|
277,592
|
|
|
658,337
|
|
||
Equity investments
|
102,410
|
|
|
75,376
|
|
||
Other investments
|
14,715
|
|
|
14,725
|
|
||
Return of invested capital from unconsolidated subsidiaries
|
10,800
|
|
|
36,154
|
|
||
Net sales or maturities (purchases) of short-term investments
|
21,623
|
|
|
219,053
|
|
||
Unsettled security transactions, net change
|
(4,171
|
)
|
|
(3,044
|
)
|
||
Purchases of capital assets
|
(5,042
|
)
|
|
(5,113
|
)
|
||
Repayments (advances) under Syndicate Credit Agreement
|
29,790
|
|
|
(1,050
|
)
|
||
Other
|
(17
|
)
|
|
—
|
|
||
Net cash provided (used) by investing activities
|
(2,720
|
)
|
|
277,898
|
|
||
Continued on the following page.
|
|
|
|
|
Six Months Ended June 30
|
||||||
|
2019
|
|
2018
|
||||
Continued from the previous page.
|
|
|
|
||||
Financing Activities
|
|
|
|
||||
Repayments under Revolving Credit Agreement
|
—
|
|
|
(123,000
|
)
|
||
Repayments of Mortgage Loans
|
(724
|
)
|
|
(698
|
)
|
||
Dividends to shareholders
|
(59,956
|
)
|
|
(283,313
|
)
|
||
Capital contribution received from (return of capital to) external segregated portfolio cell participants
|
(1,544
|
)
|
|
(329
|
)
|
||
Other
|
(2,663
|
)
|
|
(3,904
|
)
|
||
Net cash provided (used) by financing activities
|
(64,887
|
)
|
|
(411,244
|
)
|
||
Increase (decrease) in cash and cash equivalents
|
11,408
|
|
|
(67,780
|
)
|
||
Cash and cash equivalents at beginning of period
|
80,471
|
|
|
134,495
|
|
||
Cash and cash equivalents at end of period
|
$
|
91,879
|
|
|
$
|
66,715
|
|
Significant Non-Cash Transactions
|
|
|
|
||||
Dividends declared and not yet paid
|
$
|
16,656
|
|
|
$
|
17,630
|
|
Operating ROU assets obtained in exchange for operating lease liabilities
|
$
|
3,729
|
|
|
$
|
—
|
|
(In thousands)
|
|
June 30, 2019
|
|
December 31, 2018
|
||||
SPC dividends payable
|
|
$
|
51,952
|
|
|
$
|
53,604
|
|
Unpaid shareholder dividends
|
|
16,656
|
|
|
43,446
|
|
||
All other
|
|
135,332
|
|
|
102,245
|
|
||
Total other liabilities
|
|
$
|
203,940
|
|
|
$
|
199,295
|
|
|
Level 1:
|
quoted (unadjusted) market prices in active markets for identical assets and liabilities. For ProAssurance, Level 1 inputs are generally quotes for debt or equity securities actively traded in exchange or over-the-counter markets.
|
|
Level 2:
|
market data obtained from sources independent of the reporting entity (observable inputs). For ProAssurance, Level 2 inputs generally include quoted prices in markets that are not active, quoted prices for similar assets or liabilities, and results from pricing models that use observable inputs such as interest rates and yield curves that are generally available at commonly quoted intervals.
|
|
Level 3:
|
the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances (non-observable inputs). For ProAssurance, Level 3 inputs are used in situations where little or no Level 1 or 2 inputs are available or are inappropriate given the particular circumstances. Level 3 inputs include results from pricing models for which some or all of the inputs are not observable, discounted cash flow methodologies, single non-binding broker quotes and adjustments to externally quoted prices that are based on management judgment or estimation.
|
|
June 30, 2019
|
||||||||||||||
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
110,449
|
|
|
$
|
—
|
|
|
$
|
110,449
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
29,147
|
|
|
—
|
|
|
29,147
|
|
||||
State and municipal bonds
|
—
|
|
|
290,243
|
|
|
—
|
|
|
290,243
|
|
||||
Corporate debt, multiple observable inputs
|
—
|
|
|
1,304,560
|
|
|
—
|
|
|
1,304,560
|
|
||||
Corporate debt, limited observable inputs
|
—
|
|
|
—
|
|
|
2,304
|
|
|
2,304
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
182,258
|
|
|
—
|
|
|
182,258
|
|
||||
Agency commercial mortgage-backed securities
|
—
|
|
|
11,475
|
|
|
—
|
|
|
11,475
|
|
||||
Other commercial mortgage-backed securities
|
—
|
|
|
62,769
|
|
|
1,171
|
|
|
63,940
|
|
||||
Other asset-backed securities
|
—
|
|
|
231,978
|
|
|
2,992
|
|
|
234,970
|
|
||||
Fixed maturities, trading
|
—
|
|
|
43,156
|
|
|
—
|
|
|
43,156
|
|
||||
Equity investments
|
|
|
|
|
|
|
|
||||||||
Financial
|
58,517
|
|
|
—
|
|
|
—
|
|
|
58,517
|
|
||||
Utilities/Energy
|
42,788
|
|
|
—
|
|
|
—
|
|
|
42,788
|
|
||||
Consumer oriented
|
40,588
|
|
|
—
|
|
|
—
|
|
|
40,588
|
|
||||
Industrial
|
39,186
|
|
|
—
|
|
|
—
|
|
|
39,186
|
|
||||
Bond funds
|
174,795
|
|
|
—
|
|
|
—
|
|
|
174,795
|
|
||||
All other
|
43,268
|
|
|
—
|
|
|
—
|
|
|
43,268
|
|
||||
Short-term investments
|
243,908
|
|
|
43,101
|
|
|
—
|
|
|
287,009
|
|
||||
Other investments
|
—
|
|
|
33,200
|
|
|
624
|
|
|
33,824
|
|
||||
Other assets
|
—
|
|
|
1,085
|
|
|
—
|
|
|
1,085
|
|
||||
Total assets categorized within the fair value hierarchy
|
$
|
643,050
|
|
|
$
|
2,343,421
|
|
|
$
|
7,091
|
|
|
2,993,562
|
|
|
Assets carried at NAV, which approximates fair value and which are not categorized within the fair value hierarchy, reported as a part of:
|
|
|
|
|
|
|
|
||||||||
Equity investments
|
|
|
|
|
|
|
21,283
|
|
|||||||
Investment in unconsolidated subsidiaries
|
|
|
|
|
|
|
291,000
|
|
|||||||
Total assets at fair value
|
|
|
|
|
|
|
$
|
3,305,845
|
|
|
December 31, 2018
|
||||||||||||||
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
120,201
|
|
|
$
|
—
|
|
|
$
|
120,201
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
35,354
|
|
|
—
|
|
|
35,354
|
|
||||
State and municipal bonds
|
—
|
|
|
293,772
|
|
|
—
|
|
|
293,772
|
|
||||
Corporate debt, multiple observable inputs
|
2,319
|
|
|
1,216,834
|
|
|
—
|
|
|
1,219,153
|
|
||||
Corporate debt, limited observable inputs
|
—
|
|
|
—
|
|
|
4,322
|
|
|
4,322
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
181,238
|
|
|
—
|
|
|
181,238
|
|
||||
Agency commercial mortgage-backed securities
|
—
|
|
|
13,108
|
|
|
—
|
|
|
13,108
|
|
||||
Other commercial mortgage-backed securities
|
—
|
|
|
30,993
|
|
|
—
|
|
|
30,993
|
|
||||
Other asset-backed securities
|
—
|
|
|
191,807
|
|
|
3,850
|
|
|
195,657
|
|
||||
Fixed maturities, trading
|
—
|
|
|
38,188
|
|
|
—
|
|
|
38,188
|
|
||||
Equity investments
|
|
|
|
|
|
|
|
||||||||
Financial
|
62,344
|
|
|
—
|
|
|
—
|
|
|
62,344
|
|
||||
Utilities/Energy
|
46,533
|
|
|
—
|
|
|
—
|
|
|
46,533
|
|
||||
Consumer oriented
|
47,462
|
|
|
—
|
|
|
—
|
|
|
47,462
|
|
||||
Industrial
|
41,487
|
|
|
—
|
|
|
—
|
|
|
41,487
|
|
||||
Bond funds
|
174,753
|
|
|
—
|
|
|
—
|
|
|
174,753
|
|
||||
All other
|
50,066
|
|
|
—
|
|
|
—
|
|
|
50,066
|
|
||||
Short-term investments
|
265,910
|
|
|
42,409
|
|
|
—
|
|
|
308,319
|
|
||||
Other investments
|
—
|
|
|
31,341
|
|
|
3
|
|
|
31,344
|
|
||||
Other assets
|
—
|
|
|
1,884
|
|
|
—
|
|
|
1,884
|
|
||||
Total assets categorized within the fair value hierarchy
|
$
|
690,874
|
|
|
$
|
2,197,129
|
|
|
$
|
8,175
|
|
|
2,896,178
|
|
|
Assets carried at NAV, which approximates fair value and which are not categorized within the fair value hierarchy, reported as a part of:
|
|
|
|
|
|
|
|
||||||||
Equity investments
|
|
|
|
|
|
|
20,292
|
|
|||||||
Investment in unconsolidated subsidiaries
|
|
|
|
|
|
|
268,436
|
|
|||||||
Total assets at fair value
|
|
|
|
|
|
|
$
|
3,184,906
|
|
|
|
Fair Value at
|
|
|
|
|
|
|
||
($ in thousands)
|
|
June 30, 2019
|
|
December 31, 2018
|
|
Valuation Technique
|
|
Unobservable Input
|
|
Range
(Weighted Average) |
Assets:
|
|
|
|
|
|
|
|
|
|
|
Corporate debt, limited observable inputs
|
|
$2,304
|
|
$4,322
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
Other commercial mortgage-backed securities
|
|
$1,171
|
|
—
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
Other asset-backed securities
|
|
$2,992
|
|
$3,850
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
Other investments
|
|
$624
|
|
$3
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 10% (5%)
|
|
June 30, 2019
|
||||||||||||||
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||
(In thousands)
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||
Balance March 31, 2019
|
$
|
4,296
|
|
|
$
|
4,132
|
|
|
$
|
3
|
|
|
$
|
8,431
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
||||||||
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
||||||||
Net investment income
|
—
|
|
|
(22
|
)
|
|
—
|
|
|
(22
|
)
|
||||
Net realized investment gains (losses)
|
—
|
|
|
—
|
|
|
33
|
|
|
33
|
|
||||
Included in other comprehensive income
|
8
|
|
|
53
|
|
|
—
|
|
|
61
|
|
||||
Purchases
|
—
|
|
|
—
|
|
|
170
|
|
|
170
|
|
||||
Sales
|
(2,000
|
)
|
|
—
|
|
|
—
|
|
|
(2,000
|
)
|
||||
Transfers in
|
—
|
|
|
—
|
|
|
418
|
|
|
418
|
|
||||
Transfers out
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Balance June 30, 2019
|
$
|
2,304
|
|
|
$
|
4,163
|
|
|
$
|
624
|
|
|
$
|
7,091
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
June 30, 2019
|
||||||||||||||
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||
(In thousands)
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||
Balance December 31, 2018
|
$
|
4,322
|
|
|
$
|
3,850
|
|
|
$
|
3
|
|
|
$
|
8,175
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
||||||||
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
||||||||
Net investment income
|
2
|
|
|
(140
|
)
|
|
—
|
|
|
(138
|
)
|
||||
Net realized investment gains (losses)
|
—
|
|
|
—
|
|
|
33
|
|
|
33
|
|
||||
Included in other comprehensive income
|
11
|
|
|
210
|
|
|
—
|
|
|
221
|
|
||||
Purchases
|
1,305
|
|
|
—
|
|
|
170
|
|
|
1,475
|
|
||||
Sales
|
(2,136
|
)
|
|
(6
|
)
|
|
—
|
|
|
(2,142
|
)
|
||||
Transfers in
|
—
|
|
|
1,200
|
|
|
418
|
|
|
1,618
|
|
||||
Transfers out
|
(1,200
|
)
|
|
(951
|
)
|
|
—
|
|
|
(2,151
|
)
|
||||
Balance June 30, 2019
|
$
|
2,304
|
|
|
$
|
4,163
|
|
|
$
|
624
|
|
|
$
|
7,091
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
June 30, 2018
|
||||||||||||||
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||
(In thousands)
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||
Balance March 31, 2018
|
$
|
15,097
|
|
|
$
|
17,323
|
|
|
$
|
365
|
|
|
$
|
32,785
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
||||||||
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
||||||||
Net investment income
|
(36
|
)
|
|
1
|
|
|
—
|
|
|
(35
|
)
|
||||
Net realized investment gains (losses)
|
(8
|
)
|
|
—
|
|
|
6
|
|
|
(2
|
)
|
||||
Included in other comprehensive income
|
(90
|
)
|
|
(111
|
)
|
|
—
|
|
|
(201
|
)
|
||||
Purchases
|
—
|
|
|
3,225
|
|
|
—
|
|
|
3,225
|
|
||||
Sales
|
(1,644
|
)
|
|
(158
|
)
|
|
(366
|
)
|
|
(2,168
|
)
|
||||
Transfers in
|
558
|
|
|
—
|
|
|
—
|
|
|
558
|
|
||||
Transfers out
|
(5,497
|
)
|
|
(10,860
|
)
|
|
—
|
|
|
(16,357
|
)
|
||||
Balance June 30, 2018
|
$
|
8,380
|
|
|
$
|
9,420
|
|
|
$
|
5
|
|
|
$
|
17,805
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
June 30, 2018
|
||||||||||||||
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||
(In thousands)
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||
Balance December 31, 2017
|
$
|
13,703
|
|
|
$
|
4,986
|
|
|
$
|
409
|
|
|
$
|
19,098
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
||||||||
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
||||||||
Net investment income
|
(74
|
)
|
|
1
|
|
|
—
|
|
|
(73
|
)
|
||||
Net realized investment gains (losses)
|
(8
|
)
|
|
—
|
|
|
(38
|
)
|
|
(46
|
)
|
||||
Included in other comprehensive income
|
(128
|
)
|
|
(141
|
)
|
|
—
|
|
|
(269
|
)
|
||||
Purchases
|
6,005
|
|
|
16,678
|
|
|
—
|
|
|
22,683
|
|
||||
Sales
|
(4,549
|
)
|
|
(185
|
)
|
|
(366
|
)
|
|
(5,100
|
)
|
||||
Transfers in
|
2,627
|
|
|
—
|
|
|
—
|
|
|
2,627
|
|
||||
Transfers out
|
(9,196
|
)
|
|
(11,919
|
)
|
|
—
|
|
|
(21,115
|
)
|
||||
Balance June 30, 2018
|
$
|
8,380
|
|
|
$
|
9,420
|
|
|
$
|
5
|
|
|
$
|
17,805
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Unfunded
Commitments |
|
Fair Value
|
||||||
(In thousands)
|
June 30,
2019 |
|
June 30,
2019 |
|
December 31,
2018 |
||||
Equity investments:
|
|
|
|
|
|
||||
Mortgage fund (1)
|
None
|
|
$
|
21,283
|
|
|
$
|
20,292
|
|
Investment in unconsolidated subsidiaries:
|
|
|
|
|
|
||||
Private debt funds (2)
|
$18,333
|
|
14,032
|
|
|
18,196
|
|
||
Long equity fund (3)
|
None
|
|
6,511
|
|
|
6,561
|
|
||
Long/short equity funds (4)
|
None
|
|
29,066
|
|
|
28,805
|
|
||
Non-public equity funds (5)
|
$82,544
|
|
122,411
|
|
|
114,811
|
|
||
Multi-strategy fund of funds (6)
|
None
|
|
9,596
|
|
|
9,322
|
|
||
Credit funds (7)
|
$2,971
|
|
40,838
|
|
|
29,164
|
|
||
Long/short commodities fund (8)
|
None
|
|
14,287
|
|
|
12,958
|
|
||
Strategy focused funds (9)
|
$48,228
|
|
54,259
|
|
|
48,619
|
|
||
|
|
|
291,000
|
|
|
268,436
|
|
||
Total investments carried at NAV
|
|
|
$
|
312,283
|
|
|
$
|
288,728
|
|
(1)
|
This investment fund is focused on the structured mortgage market. The fund will primarily invest in U.S. Agency mortgage-backed securities. Redemptions are allowed at the end of any calendar quarter with a prior notice requirement of 65 days and are paid within 45 days at the end of the redemption dealing day.
|
(2)
|
This investment is comprised of interests in three unrelated LP funds that are structured to provide interest distributions primarily through diversified portfolios of private debt instruments. One LP allows redemption by special consent; the other two do not permit redemption. Income and capital are to be periodically distributed at the discretion of the LPs over an anticipated time frame that spans from three to eight years.
|
(3)
|
This fund is a LP that holds long equities of public international companies. Redemptions are allowed at the end of any calendar month with a prior notice requirement of 15 days and are paid within 10 days of the end of the calendar month of the redemption request.
|
(4)
|
This investment is comprised of interests in multiple unrelated LP funds. The funds hold primarily long and short North American equities and target absolute returns using strategies designed to take advantage of market opportunities. The funds generally permit quarterly or semi-annual capital redemptions subject to notice requirements of 30 to 90 days. For some funds, redemptions above specified thresholds (lowest threshold is 90%) may be only partially payable until after a fund audit is completed and are then payable within 30 days.
|
(5)
|
This investment is comprised of interests in multiple unrelated LP funds, each structured to provide capital appreciation through diversified investments in private equity, which can include investments in buyout, venture capital, debt including senior, second lien and mezzanine, distressed debt, collateralized loan obligations and other private equity-oriented LPs. Two of the LPs allow redemption by terms set forth in the LP agreements; the others do not permit redemption. Income and capital are to be periodically distributed at the discretion of the LP over time frames that are anticipated to span up to ten years.
|
(6)
|
This fund is a LLC structured to build and manage low volatility, multi-manager portfolios that have little or no correlation to the broader fixed income and equity security markets. Redemptions are not permitted but offers to repurchase units of the LLC may be extended periodically.
|
(7)
|
This investment is comprised of four unrelated LP funds. Two funds seek to obtain superior risk-adjusted absolute returns through a diversified portfolio of debt securities, including bonds, loans and other asset-backed instruments. A third fund focuses on private middle market company mezzanine loans, while the remaining fund seeks event driven opportunities across the corporate credit spectrum. Two funds are allowed redemptions at any quarter-end with a prior notice requirement of 90 days, one fund permits redemption at any quarter-end with a prior notice requirement of 180 days and one fund does not allow redemptions.
|
(8)
|
This fund is a LLC invested across a broad range of commodities and focuses primarily on market neutral, relative value strategies, seeking to generate absolute returns with low correlation to broad commodity, equity and fixed income markets. Following an initial one-year lock-up period, redemptions are allowed with a prior notice requirement of 30 days and are payable within 30 days.
|
|
June 30, 2019
|
||||||||||||||
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
108,961
|
|
|
$
|
1,655
|
|
|
$
|
167
|
|
|
$
|
110,449
|
|
U.S. Government-sponsored enterprise obligations
|
29,035
|
|
|
141
|
|
|
29
|
|
|
29,147
|
|
||||
State and municipal bonds
|
279,664
|
|
|
10,591
|
|
|
12
|
|
|
290,243
|
|
||||
Corporate debt
|
1,283,074
|
|
|
26,112
|
|
|
2,322
|
|
|
1,306,864
|
|
||||
Residential mortgage-backed securities
|
181,183
|
|
|
2,140
|
|
|
1,065
|
|
|
182,258
|
|
||||
Agency commercial mortgage-backed securities
|
11,271
|
|
|
224
|
|
|
20
|
|
|
11,475
|
|
||||
Other commercial mortgage-backed securities
|
62,593
|
|
|
1,381
|
|
|
34
|
|
|
63,940
|
|
||||
Other asset-backed securities
|
232,766
|
|
|
2,292
|
|
|
88
|
|
|
234,970
|
|
||||
|
$
|
2,188,547
|
|
|
$
|
44,536
|
|
|
$
|
3,737
|
|
|
$
|
2,229,346
|
|
|
|
|
|
|
|
|
|
||||||||
|
December 31, 2018
|
||||||||||||||
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
121,274
|
|
|
$
|
331
|
|
|
$
|
1,404
|
|
|
$
|
120,201
|
|
U.S. Government-sponsored enterprise obligations
|
35,758
|
|
|
25
|
|
|
429
|
|
|
35,354
|
|
||||
State and municipal bonds
|
289,544
|
|
|
4,877
|
|
|
649
|
|
|
293,772
|
|
||||
Corporate debt
|
1,244,577
|
|
|
3,328
|
|
|
24,430
|
|
|
1,223,475
|
|
||||
Residential mortgage-backed securities
|
184,463
|
|
|
814
|
|
|
4,039
|
|
|
181,238
|
|
||||
Agency commercial mortgage-backed securities
|
13,296
|
|
|
12
|
|
|
200
|
|
|
13,108
|
|
||||
Other commercial mortgage-backed securities
|
31,330
|
|
|
38
|
|
|
375
|
|
|
30,993
|
|
||||
Other asset-backed securities
|
196,583
|
|
|
254
|
|
|
1,180
|
|
|
195,657
|
|
||||
|
$
|
2,116,825
|
|
|
$
|
9,679
|
|
|
$
|
32,706
|
|
|
$
|
2,093,798
|
|
(In thousands)
|
Amortized
Cost |
|
Due in one
year or less |
|
Due after
one year through five years |
|
Due after
five years through ten years |
|
Due after
ten years |
|
Total Fair
Value |
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
108,961
|
|
|
$
|
16,545
|
|
|
$
|
71,405
|
|
|
$
|
22,076
|
|
|
$
|
423
|
|
|
$
|
110,449
|
|
U.S. Government-sponsored enterprise obligations
|
29,035
|
|
|
5,391
|
|
|
6,005
|
|
|
17,608
|
|
|
143
|
|
|
29,147
|
|
||||||
State and municipal bonds
|
279,664
|
|
|
14,647
|
|
|
116,908
|
|
|
133,199
|
|
|
25,489
|
|
|
290,243
|
|
||||||
Corporate debt
|
1,283,074
|
|
|
154,196
|
|
|
782,386
|
|
|
343,561
|
|
|
26,721
|
|
|
1,306,864
|
|
||||||
Residential mortgage-backed securities
|
181,183
|
|
|
|
|
|
|
|
|
|
|
182,258
|
|
||||||||||
Agency commercial mortgage-backed securities
|
11,271
|
|
|
|
|
|
|
|
|
|
|
11,475
|
|
||||||||||
Other commercial mortgage-backed securities
|
62,593
|
|
|
|
|
|
|
|
|
|
|
63,940
|
|
||||||||||
Other asset-backed securities
|
232,766
|
|
|
|
|
|
|
|
|
|
|
234,970
|
|
||||||||||
|
$
|
2,188,547
|
|
|
|
|
|
|
|
|
|
|
$
|
2,229,346
|
|
|
June 30, 2019
|
||||||||||||||||||||||
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
34,577
|
|
|
$
|
167
|
|
|
$
|
2,006
|
|
|
$
|
12
|
|
|
$
|
32,571
|
|
|
$
|
155
|
|
U.S. Government-sponsored enterprise obligations
|
9,372
|
|
|
29
|
|
|
1,986
|
|
|
14
|
|
|
7,386
|
|
|
15
|
|
||||||
State and municipal bonds
|
4,589
|
|
|
12
|
|
|
2,663
|
|
|
7
|
|
|
1,926
|
|
|
5
|
|
||||||
Corporate debt
|
242,882
|
|
|
2,322
|
|
|
46,959
|
|
|
514
|
|
|
195,923
|
|
|
1,808
|
|
||||||
Residential mortgage-backed securities
|
81,377
|
|
|
1,065
|
|
|
1,166
|
|
|
1
|
|
|
80,211
|
|
|
1,064
|
|
||||||
Agency commercial mortgage-backed securities
|
317
|
|
|
20
|
|
|
—
|
|
|
—
|
|
|
317
|
|
|
20
|
|
||||||
Other commercial mortgage-backed securities
|
4,163
|
|
|
34
|
|
|
—
|
|
|
—
|
|
|
4,163
|
|
|
34
|
|
||||||
Other asset-backed securities
|
42,436
|
|
|
88
|
|
|
4,660
|
|
|
1
|
|
|
37,776
|
|
|
87
|
|
||||||
|
$
|
419,713
|
|
|
$
|
3,737
|
|
|
$
|
59,440
|
|
|
$
|
549
|
|
|
$
|
360,273
|
|
|
$
|
3,188
|
|
|
December 31, 2018
|
||||||||||||||||||||||
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
97,969
|
|
|
$
|
1,405
|
|
|
$
|
20,221
|
|
|
$
|
119
|
|
|
$
|
77,748
|
|
|
$
|
1,286
|
|
U.S. Government-sponsored enterprise obligations
|
33,677
|
|
|
429
|
|
|
20,479
|
|
|
126
|
|
|
13,198
|
|
|
303
|
|
||||||
State and municipal bonds
|
63,094
|
|
|
648
|
|
|
30,924
|
|
|
143
|
|
|
32,170
|
|
|
505
|
|
||||||
Corporate debt
|
938,651
|
|
|
24,429
|
|
|
447,891
|
|
|
8,804
|
|
|
490,760
|
|
|
15,625
|
|
||||||
Residential mortgage-backed securities
|
157,120
|
|
|
4,039
|
|
|
27,311
|
|
|
209
|
|
|
129,809
|
|
|
3,830
|
|
||||||
Agency commercial mortgage-backed securities
|
9,822
|
|
|
200
|
|
|
4,566
|
|
|
22
|
|
|
5,256
|
|
|
178
|
|
||||||
Other commercial mortgage-backed securities
|
22,924
|
|
|
375
|
|
|
13,348
|
|
|
164
|
|
|
9,576
|
|
|
211
|
|
||||||
Other asset-backed securities
|
142,470
|
|
|
1,181
|
|
|
70,218
|
|
|
236
|
|
|
72,252
|
|
|
945
|
|
||||||
|
$
|
1,465,727
|
|
|
$
|
32,706
|
|
|
$
|
634,958
|
|
|
$
|
9,823
|
|
|
$
|
830,769
|
|
|
$
|
22,883
|
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
(In millions)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Proceeds from sales (exclusive of maturities and paydowns)
|
$
|
61.8
|
|
|
$
|
115.8
|
|
|
$
|
93.3
|
|
|
$
|
495.0
|
|
Purchases
|
$
|
171.8
|
|
|
$
|
184.6
|
|
|
$
|
350.9
|
|
|
$
|
552.5
|
|
|
Three Months Ended
June 30 |
|
Six Months Ended
June 30 |
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Fixed maturities
|
$
|
18,275
|
|
|
$
|
17,506
|
|
|
$
|
35,792
|
|
|
$
|
34,586
|
|
Equities
|
4,990
|
|
|
4,998
|
|
|
9,813
|
|
|
9,865
|
|
||||
Short-term investments, including Other
|
1,619
|
|
|
1,332
|
|
|
3,454
|
|
|
2,639
|
|
||||
BOLI
|
459
|
|
|
455
|
|
|
912
|
|
|
904
|
|
||||
Investment fees and expenses
|
(1,804
|
)
|
|
(1,907
|
)
|
|
(3,614
|
)
|
|
(3,583
|
)
|
||||
Net investment income
|
$
|
23,539
|
|
|
$
|
22,384
|
|
|
$
|
46,357
|
|
|
$
|
44,411
|
|
|
June 30, 2019
|
|
Carrying Value
|
|||||||
(In thousands)
|
Percentage
Ownership |
|
June 30,
2019 |
|
December 31,
2018 |
|||||
Qualified affordable housing project tax credit partnerships
|
See below
|
|
$
|
56,067
|
|
|
$
|
65,677
|
|
|
Other tax credit partnerships
|
See below
|
|
3,266
|
|
|
3,757
|
|
|||
All other investments, primarily investment fund LPs/LLCs
|
See below
|
|
326,298
|
|
|
298,323
|
|
|||
|
|
|
$
|
385,631
|
|
|
$
|
367,757
|
|
|
Three Months Ended
June 30 |
|
Six Months Ended
June 30 |
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Qualified affordable housing project tax credit partnerships
|
|
|
|
|
|
|
|
||||||||
Losses recorded
|
$
|
5,167
|
|
|
$
|
5,612
|
|
|
$
|
9,597
|
|
|
$
|
9,712
|
|
Tax credits recognized
|
$
|
4,531
|
|
|
$
|
4,624
|
|
|
$
|
9,063
|
|
|
$
|
9,237
|
|
|
|
|
|
|
|
|
|
||||||||
Historic tax credit partnerships
|
|
|
|
|
|
|
|
||||||||
Losses recorded
|
$
|
302
|
|
|
$
|
1,506
|
|
|
$
|
491
|
|
|
$
|
3,382
|
|
Tax credits recognized
|
$
|
103
|
|
|
$
|
693
|
|
|
$
|
206
|
|
|
$
|
1,355
|
|
|
Three Months Ended
June 30 |
|
Six Months Ended
June 30 |
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Total OTTI losses:
|
|
|
|
|
|
|
|
||||||||
Corporate debt
|
$
|
—
|
|
|
$
|
(404
|
)
|
|
$
|
(136
|
)
|
|
$
|
(404
|
)
|
Portion of OTTI losses recognized in other comprehensive income before taxes:
|
|
|
|
|
|
|
|
||||||||
Corporate debt
|
—
|
|
|
—
|
|
|
87
|
|
|
—
|
|
||||
Net impairment losses recognized in earnings
|
—
|
|
|
(404
|
)
|
|
(49
|
)
|
|
(404
|
)
|
||||
Gross realized gains, available-for-sale fixed maturities
|
1,006
|
|
|
438
|
|
|
1,374
|
|
|
4,902
|
|
||||
Gross realized (losses), available-for-sale fixed maturities
|
(33
|
)
|
|
(1,725
|
)
|
|
(369
|
)
|
|
(3,772
|
)
|
||||
Net realized gains (losses), trading fixed maturities
|
2
|
|
|
(73
|
)
|
|
(25
|
)
|
|
(73
|
)
|
||||
Net realized gains (losses), equity investments
|
9,218
|
|
|
3,488
|
|
|
11,008
|
|
|
12,706
|
|
||||
Net realized gains (losses), other investments
|
198
|
|
|
402
|
|
|
577
|
|
|
1,090
|
|
||||
Change in unrealized holding gains (losses), trading fixed maturities
|
265
|
|
|
(170
|
)
|
|
475
|
|
|
(219
|
)
|
||||
Change in unrealized holding gains (losses), equity investments
|
(2,459
|
)
|
|
745
|
|
|
29,932
|
|
|
(23,099
|
)
|
||||
Change in unrealized holding gains (losses), convertible securities, carried at fair value
|
1,110
|
|
|
90
|
|
|
3,006
|
|
|
(864
|
)
|
||||
Other
|
1
|
|
|
4
|
|
|
2
|
|
|
11
|
|
||||
Net realized investment gains (losses)
|
$
|
9,308
|
|
|
$
|
2,795
|
|
|
$
|
45,931
|
|
|
$
|
(9,722
|
)
|
|
Three Months Ended
June 30 |
|
Six Months Ended
June 30 |
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Balance beginning of period
|
$
|
142
|
|
|
$
|
1,313
|
|
|
$
|
93
|
|
|
$
|
1,313
|
|
Additional credit losses recognized during the period, related to securities for which:
|
|
|
|
|
|
|
|
||||||||
No OTTI has been previously recognized
|
—
|
|
|
—
|
|
|
49
|
|
|
—
|
|
||||
Balance June 30
|
$
|
142
|
|
|
$
|
1,313
|
|
|
$
|
142
|
|
|
$
|
1,313
|
|
($ in thousands)
|
June 30, 2019
|
||
Operating lease ROU assets
|
$
|
20,374
|
|
Operating lease liabilities
|
$
|
21,131
|
|
Weighted-average remaining lease term
|
8.89 years
|
|
|
Weighted-average discount rate
|
3.21
|
%
|
|
Six Months Ended June 30
|
|||||
(In thousands)
|
2019
|
2018
|
||||
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|
||||
Operating cash flows from operating leases
|
$
|
757
|
|
$
|
178
|
|
(In thousands)
|
|
||
2019
|
$
|
2,178
|
|
2020
|
3,883
|
|
|
2021
|
3,530
|
|
|
2022
|
2,648
|
|
|
2023
|
1,955
|
|
|
Thereafter
|
10,142
|
|
|
Total future minimum lease payments
|
$
|
24,336
|
|
Less: Imputed interest
|
3,205
|
|
|
Total operating lease liabilities
|
$
|
21,131
|
|
(In thousands)
|
June 30,
2019 |
|
December 31,
2018 |
||||
Senior Notes due 2023, unsecured, interest at 5.3% annually
|
$
|
250,000
|
|
|
$
|
250,000
|
|
Revolving Credit Agreement, outstanding borrowings are not permitted to exceed $250 million aggregately; Revolving Credit Agreement expires in 2020. The interest rate on borrowings is set at the time the borrowing is initiated or renewed.
|
—
|
|
|
—
|
|
||
Mortgage Loans, outstanding borrowings are secured by first priority liens on two office buildings, and bear an interest rate of three-month LIBOR plus 1.325% (3.77% and 4.10%, respectively) determined on a quarterly basis.
|
38,340
|
|
|
39,064
|
|
||
Total principal
|
288,340
|
|
|
289,064
|
|
||
Less debt issuance costs
|
1,123
|
|
|
1,307
|
|
||
Debt less debt issuance costs
|
$
|
287,217
|
|
|
$
|
287,757
|
|
|
Gains (Losses) Recognized in
Income on Derivatives
|
|||||||||||||||
(In thousands)
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
|||||||||||||
Derivatives Not Designated as Hedging Instruments
|
Location in the Condensed Consolidated Statements of Income and Comprehensive Income
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Interest Rate Cap
|
Interest expense
|
$
|
(362
|
)
|
|
$
|
282
|
|
|
$
|
(799
|
)
|
|
$
|
857
|
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Share-based compensation expense
|
$
|
1,092
|
|
|
$
|
1,615
|
|
|
$
|
2,320
|
|
|
$
|
2,517
|
|
Related tax benefits
|
$
|
229
|
|
|
$
|
339
|
|
|
$
|
487
|
|
|
$
|
529
|
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Reclassifications from AOCI to net income:
|
|
|
|
|
|
|
|
||||||||
Realized investment gains (losses)
|
$
|
974
|
|
|
$
|
(1,691
|
)
|
|
$
|
957
|
|
|
$
|
726
|
|
Tax effect, calculated using the 21% federal statutory tax rate
|
(205
|
)
|
|
355
|
|
|
(201
|
)
|
|
(153
|
)
|
||||
Net reclassification adjustments
|
$
|
769
|
|
|
$
|
(1,336
|
)
|
|
$
|
756
|
|
|
$
|
573
|
|
|
|
|
|
|
|
|
|
||||||||
Deferred tax expense (benefit) included in OCI
|
$
|
6,177
|
|
|
$
|
(2,185
|
)
|
|
$
|
12,982
|
|
|
$
|
(9,245
|
)
|
(In thousands, except per share data)
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
2019
|
|
2018
|
|
2019
|
|
2018
|
|||||||||
Weighted average number of common shares outstanding, basic
|
53,750
|
|
|
53,610
|
|
|
53,716
|
|
|
53,567
|
|
||||
Dilutive effect of securities:
|
|
|
|
|
|
|
|
||||||||
Restricted Share Units
|
53
|
|
|
69
|
|
|
67
|
|
|
75
|
|
||||
Performance Share Units
|
10
|
|
|
42
|
|
|
20
|
|
|
54
|
|
||||
Purchase Match Units
|
15
|
|
|
20
|
|
|
15
|
|
|
20
|
|
||||
Weighted average number of common shares outstanding, diluted
|
53,828
|
|
|
53,741
|
|
|
53,818
|
|
|
53,716
|
|
||||
Effect of dilutive shares on earnings per share
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Three Months Ended June 30, 2019
|
||||||||||||||||||||||||||
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation Insurance
|
|
Segregated Portfolio Cell Reinsurance
|
|
Lloyd's Syndicates
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||||
Net premiums earned
|
$
|
126,011
|
|
|
$
|
46,574
|
|
|
$
|
19,284
|
|
|
$
|
17,280
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
209,149
|
|
Net investment income
|
—
|
|
|
—
|
|
|
368
|
|
|
1,199
|
|
|
21,972
|
|
|
—
|
|
|
23,539
|
|
|||||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,152
|
)
|
|
—
|
|
|
(5,152
|
)
|
|||||||
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
(94
|
)
|
|
262
|
|
|
9,140
|
|
|
—
|
|
|
9,308
|
|
|||||||
Other income (expense)*
|
1,470
|
|
|
725
|
|
|
135
|
|
|
32
|
|
|
833
|
|
|
(418
|
)
|
|
2,777
|
|
|||||||
Net losses and loss adjustment expenses
|
(106,017
|
)
|
|
(30,625
|
)
|
|
(19,973
|
)
|
|
(11,825
|
)
|
|
—
|
|
|
—
|
|
|
(168,440
|
)
|
|||||||
Underwriting, policy acquisition and operating expenses*
|
(29,863
|
)
|
|
(14,368
|
)
|
|
(5,905
|
)
|
|
(7,564
|
)
|
|
(5,426
|
)
|
|
418
|
|
|
(62,708
|
)
|
|||||||
Segregated portfolio cells dividend (expense) income
|
—
|
|
|
—
|
|
|
7,033
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,033
|
|
|||||||
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,247
|
)
|
|
—
|
|
|
(4,247
|
)
|
|||||||
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
—
|
|
|
304
|
|
|
(27
|
)
|
|
—
|
|
|
277
|
|
|||||||
Segment operating results
|
$
|
(8,399
|
)
|
|
$
|
2,306
|
|
|
$
|
848
|
|
|
$
|
(312
|
)
|
|
$
|
17,093
|
|
|
$
|
—
|
|
|
$
|
11,536
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Depreciation and amortization, net of accretion
|
$
|
1,623
|
|
|
$
|
959
|
|
|
$
|
(32
|
)
|
|
$
|
(4
|
)
|
|
$
|
2,071
|
|
|
$
|
—
|
|
|
$
|
4,617
|
|
|
Six Months Ended June 30, 2019
|
||||||||||||||||||||||||||
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation Insurance
|
|
Segregated Portfolio Cell Reinsurance
|
|
Lloyd's Syndicates
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||||
Net premiums earned
|
$
|
250,079
|
|
|
$
|
92,512
|
|
|
$
|
38,787
|
|
|
$
|
35,920
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
417,298
|
|
Net investment income
|
—
|
|
|
—
|
|
|
815
|
|
|
2,205
|
|
|
43,337
|
|
|
—
|
|
|
46,357
|
|
|||||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,962
|
)
|
|
—
|
|
|
(5,962
|
)
|
|||||||
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
2,047
|
|
|
440
|
|
|
43,444
|
|
|
—
|
|
|
45,931
|
|
|||||||
Other income (expense)*
|
2,680
|
|
|
1,454
|
|
|
221
|
|
|
(114
|
)
|
|
1,738
|
|
|
(1,107
|
)
|
|
4,872
|
|
|||||||
Net losses and loss adjustment expenses
|
(213,675
|
)
|
|
(61,068
|
)
|
|
(30,719
|
)
|
|
(22,733
|
)
|
|
—
|
|
|
—
|
|
|
(328,195
|
)
|
|||||||
Underwriting, policy acquisition and operating expenses*
|
(59,480
|
)
|
|
(28,559
|
)
|
|
(11,138
|
)
|
|
(16,033
|
)
|
|
(9,997
|
)
|
|
1,107
|
|
|
(124,100
|
)
|
|||||||
Segregated portfolio cells dividend (expense) income
|
—
|
|
|
—
|
|
|
2,246
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,246
|
|
|||||||
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8,576
|
)
|
|
—
|
|
|
(8,576
|
)
|
|||||||
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(6,685
|
)
|
|
—
|
|
|
(6,685
|
)
|
|||||||
Segment operating results
|
$
|
(20,396
|
)
|
|
$
|
4,339
|
|
|
$
|
2,259
|
|
|
$
|
(315
|
)
|
|
$
|
57,299
|
|
|
$
|
—
|
|
|
$
|
43,186
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Depreciation and amortization, net of accretion
|
$
|
3,359
|
|
|
$
|
1,936
|
|
|
$
|
14
|
|
|
$
|
(7
|
)
|
|
$
|
4,351
|
|
|
$
|
—
|
|
|
$
|
9,653
|
|
|
Three Months Ended June 30, 2018
|
||||||||||||||||||||||||||
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation Insurance
|
|
Segregated Portfolio Cell Reinsurance
|
|
Lloyd's Syndicates
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||||
Net premiums earned
|
$
|
142,619
|
|
|
$
|
45,234
|
|
|
$
|
18,248
|
|
|
$
|
17,490
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
223,591
|
|
Net investment income
|
—
|
|
|
—
|
|
|
373
|
|
|
836
|
|
|
21,175
|
|
|
—
|
|
|
22,384
|
|
|||||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,380
|
|
|
—
|
|
|
5,380
|
|
|||||||
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
(457
|
)
|
|
(252
|
)
|
|
3,504
|
|
|
—
|
|
|
2,795
|
|
|||||||
Other income (expense)*
|
1,262
|
|
|
602
|
|
|
60
|
|
|
(436
|
)
|
|
1,095
|
|
|
(539
|
)
|
|
2,044
|
|
|||||||
Net losses and loss adjustment expenses
|
(110,856
|
)
|
|
(29,319
|
)
|
|
(9,048
|
)
|
|
(12,505
|
)
|
|
—
|
|
|
—
|
|
|
(161,728
|
)
|
|||||||
Underwriting, policy acquisition and operating expenses*
|
(27,922
|
)
|
|
(13,107
|
)
|
|
(5,440
|
)
|
|
(8,060
|
)
|
|
(5,621
|
)
|
|
539
|
|
|
(59,611
|
)
|
|||||||
Segregated portfolio cells dividend (expense) income
|
—
|
|
|
—
|
|
|
(2,785
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,785
|
)
|
|||||||
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,958
|
)
|
|
—
|
|
|
(3,958
|
)
|
|||||||
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
311
|
|
|
—
|
|
|
311
|
|
|||||||
Segment operating results
|
$
|
5,103
|
|
|
$
|
3,410
|
|
|
$
|
951
|
|
|
$
|
(2,927
|
)
|
|
$
|
21,886
|
|
|
$
|
—
|
|
|
$
|
28,423
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Depreciation and amortization, net of accretion
|
$
|
1,761
|
|
|
$
|
958
|
|
|
$
|
149
|
|
|
$
|
(2
|
)
|
|
$
|
2,091
|
|
|
$
|
—
|
|
|
$
|
4,957
|
|
|
Six Months Ended June 30, 2018
|
||||||||||||||||||||||||||
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation Insurance
|
|
Segregated Portfolio Cell Reinsurance
|
|
Lloyd's Syndicates
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||||
Net premiums earned
|
$
|
257,567
|
|
|
$
|
87,934
|
|
|
$
|
35,284
|
|
|
$
|
29,965
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
410,750
|
|
Net investment income
|
—
|
|
|
—
|
|
|
729
|
|
|
1,587
|
|
|
42,095
|
|
|
—
|
|
|
44,411
|
|
|||||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,019
|
|
|
—
|
|
|
7,019
|
|
|||||||
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
(930
|
)
|
|
(306
|
)
|
|
(8,486
|
)
|
|
—
|
|
|
(9,722
|
)
|
|||||||
Other income (expense)*
|
2,519
|
|
|
1,453
|
|
|
90
|
|
|
(105
|
)
|
|
2,037
|
|
|
(1,227
|
)
|
|
4,767
|
|
|||||||
Net losses and loss adjustment expenses
|
(194,380
|
)
|
|
(57,143
|
)
|
|
(19,001
|
)
|
|
(20,991
|
)
|
|
—
|
|
|
—
|
|
|
(291,515
|
)
|
|||||||
Underwriting, policy acquisition and operating expenses*
|
(55,902
|
)
|
|
(26,137
|
)
|
|
(10,554
|
)
|
|
(15,306
|
)
|
|
(10,297
|
)
|
|
1,227
|
|
|
(116,969
|
)
|
|||||||
Segregated portfolio cells dividend (expense) income
|
—
|
|
|
—
|
|
|
(4,532
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,532
|
)
|
|||||||
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,663
|
)
|
|
—
|
|
|
(7,663
|
)
|
|||||||
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
—
|
|
|
(6
|
)
|
|
3,739
|
|
|
—
|
|
|
3,733
|
|
|||||||
Segment operating results
|
$
|
9,804
|
|
|
$
|
6,107
|
|
|
$
|
1,086
|
|
|
$
|
(5,162
|
)
|
|
$
|
28,444
|
|
|
$
|
—
|
|
|
$
|
40,279
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Depreciation and amortization, net of accretion
|
$
|
3,628
|
|
|
$
|
1,914
|
|
|
$
|
310
|
|
|
$
|
(3
|
)
|
|
$
|
5,187
|
|
|
$
|
—
|
|
|
$
|
11,036
|
|
* As a result of the third quarter 2018 segment reorganization, certain fees for services provided to the SPCs at Inova Re and Eastern Re are recorded as expenses within the Segregated Portfolio Cell Reinsurance segment and as other income within the Workers' Compensation Insurance segment. These fees are eliminated between segments in consolidation. These services primarily include SPC rental fees and were previously eliminated within the Company's Workers' Compensation segment.
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Specialty P&C Segment
|
|
|
|
|
|
|
|
||||||||
Gross premiums earned:
|
|
|
|
|
|
|
|
||||||||
Healthcare professional liability
|
$
|
128,893
|
|
|
$
|
146,208
|
|
|
$
|
256,914
|
|
|
$
|
264,892
|
|
Legal professional liability
|
6,708
|
|
|
6,489
|
|
|
13,268
|
|
|
12,880
|
|
||||
Medical technology liability
|
8,356
|
|
|
8,780
|
|
|
16,658
|
|
|
17,292
|
|
||||
Other
|
1,212
|
|
|
119
|
|
|
1,346
|
|
|
230
|
|
||||
Ceded premiums earned
|
(19,158
|
)
|
|
(18,977
|
)
|
|
(38,107
|
)
|
|
(37,727
|
)
|
||||
Segment net premiums earned
|
126,011
|
|
|
142,619
|
|
|
250,079
|
|
|
257,567
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Workers' Compensation Insurance Segment
|
|
|
|
|
|
|
|
||||||||
Gross premiums earned:
|
|
|
|
|
|
|
|
||||||||
Traditional business
|
50,036
|
|
|
48,830
|
|
|
99,321
|
|
|
95,063
|
|
||||
Alternative market business
|
20,846
|
|
|
20,648
|
|
|
41,837
|
|
|
40,029
|
|
||||
Ceded premiums earned
|
(24,308
|
)
|
|
(24,244
|
)
|
|
(48,646
|
)
|
|
(47,158
|
)
|
||||
Segment net premiums earned
|
46,574
|
|
|
45,234
|
|
|
92,512
|
|
|
87,934
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Segregated Portfolio Cell Reinsurance Segment
|
|
|
|
|
|
|
|
||||||||
Gross premiums earned:
|
|
|
|
|
|
|
|
||||||||
Workers' compensation(1)
|
20,229
|
|
|
19,197
|
|
|
40,726
|
|
|
37,036
|
|
||||
Healthcare professional liability(2)
|
1,349
|
|
|
1,228
|
|
|
2,672
|
|
|
2,558
|
|
||||
Other
|
120
|
|
|
—
|
|
|
240
|
|
|
—
|
|
||||
Ceded premiums earned
|
(2,414
|
)
|
|
(2,177
|
)
|
|
(4,851
|
)
|
|
(4,310
|
)
|
||||
Segment net premiums earned
|
19,284
|
|
|
18,248
|
|
|
38,787
|
|
|
35,284
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Lloyd's Syndicates Segment
|
|
|
|
|
|
|
|
||||||||
Gross premiums earned:
|
|
|
|
|
|
|
|
||||||||
Property and casualty(3)
|
21,997
|
|
|
19,273
|
|
|
45,825
|
|
|
37,240
|
|
||||
Ceded premiums earned
|
(4,717
|
)
|
|
(1,783
|
)
|
|
(9,905
|
)
|
|
(7,275
|
)
|
||||
Segment net premiums earned
|
17,280
|
|
|
17,490
|
|
|
35,920
|
|
|
29,965
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Consolidated net premiums earned
|
$
|
209,149
|
|
|
$
|
223,591
|
|
|
$
|
417,298
|
|
|
$
|
410,750
|
|
•
|
Specialty P&C - This segment includes our professional liability business and medical technology liability business. Professional liability insurance is primarily offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. Medical technology liability insurance is offered to medical technology and life sciences companies that manufacture or distribute products including entities conducting human clinical trials. The underwriting results of SPCs that assume healthcare professional liability business were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment.
|
•
|
Workers' Compensation Insurance - This segment includes our workers' compensation insurance business which is provided primarily to employers with 1,000 or fewer employees. Our workers' compensation products include guaranteed cost, policyholder dividend policies, retrospectively-rated policies, deductible policies and alternative market solutions. The underwriting results of SPCs that assume workers’ compensation business were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment.
|
•
|
Segregated Portfolio Cell Reinsurance - This segment reflects the operating results (underwriting profit or loss, plus investment results) of SPCs at Inova Re and Eastern Re, our Cayman Islands SPC operations. Each SPC is owned, fully or in part, by an agency, group or association and the operating results of the SPCs are due to the participants of that cell. We participate to a varying degree in the results of selected SPCs and, for the SPCs in which we participate, our participation interest ranges from a low of 20% to high of 85%. SPC operating results due to external cell participants are reflected as an SPC dividend expense (income) in our Segregated Portfolio Cell Reinsurance segment. The majority of SPCs only assume workers' compensation insurance, healthcare professional liability insurance or a combination of the two from our Workers' Compensation Insurance and Specialty P&C segments. In addition, an SPC at Eastern Re assumed an errors and omissions liability policy from a captive insurer unaffiliated with ProAssurance. We do not participate in the SPC that assumed this policy; therefore, the operating results of this policy are reflected in the SPC dividend expense (income).
|
•
|
Lloyd's Syndicates - This segment includes the operating results from our participation in Lloyd's of London Syndicate 1729 and our 100% participation in Syndicate 6131, which is an SPA that underwrites on a quota share basis with Syndicate 1729. The results of this segment are normally reported on a quarter delay, except when information is available that is material to the current period. For the 2019 underwriting year, we slightly decreased our participation in the operating results of Syndicate 1729 from 62% to 61%; however, due to the quarter delay these changes were not reflected in our Lloyd's Syndicates segment results until the second quarter of 2019. Furthermore, our participation in Syndicate 6131 was not reflected in our Lloyd's Syndicates segment results until the second quarter of 2018 as Syndicate 6131 began writing business effective January 1, 2018. Syndicate 1729 underwrites risks over a wide range of property and casualty insurance and reinsurance lines in both the U.S. and international markets while Syndicate 6131 focuses on contingency and specialty property business, also within the U.S. and international markets.
|
•
|
Corporate - This segment includes our investment operations, other than those reported in our Segregated Portfolio Cell Reinsurance and Lloyd's Syndicates segments, interest expense and U.S. income taxes. The results of investment assets solely allocated to SPC operations were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment. This segment also includes non-premium revenues generated outside of our insurance entities and corporate expenses.
|
|
Distribution by GAAP Fair Value Hierarchy
|
|
|
|
|
||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Not Categorized
|
|
Total
Investments |
Investments recorded at:
|
|
|
|
|
|
|
|
|
|
Fair value
|
18%
|
|
67%
|
|
1%
|
|
9%
|
|
95%
|
Other valuations
|
|
|
|
|
|
|
|
|
5%
|
Total Investments
|
|
|
|
|
|
|
|
|
100%
|
(In millions)
|
Carrying Value
|
|
GAAP Measurement Method
|
||
Other investments:
|
|
|
|
||
Other, principally FHLB capital stock
|
$
|
2.9
|
|
|
Principally Cost
|
Investment in unconsolidated subsidiaries:
|
|
|
|
||
Investments in tax credit partnerships
|
59.3
|
|
|
Equity
|
|
Equity method investments, primarily LPs/LLCs
|
35.3
|
|
|
Equity
|
|
|
94.6
|
|
|
|
|
BOLI
|
65.0
|
|
|
Cash surrender value
|
|
Total investments - Other valuation methodologies
|
$
|
162.5
|
|
|
|
•
|
if there is intent to sell the security;
|
•
|
if it is more likely than not that the security will be required to be sold before full recovery of its amortized cost basis; or
|
•
|
if the entire amortized basis of the security is not expected to be recovered.
|
•
|
third-party research and credit rating reports;
|
•
|
the current credit standing of the issuer, including credit rating downgrades, whether before or after the balance sheet date;
|
•
|
the extent to which the decline in fair value is attributable to credit risk specifically associated with the security or its issuer;
|
•
|
internal assessments and the assessments of external portfolio managers regarding specific circumstances surrounding an investment, which indicate the investment is more or less likely to recover its amortized cost than other investments with a similar structure;
|
•
|
for asset-backed securities, the origination date of the underlying loans, the remaining average life, the probability that credit performance of the underlying loans will deteriorate in the future, and our assessment of the quality of the collateral underlying the loan;
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
•
|
any changes to the rating of the security by a rating agency; and
|
•
|
recoveries or additional declines in fair value subsequent to the balance sheet date.
|
•
|
our ability and intent to hold the investment until the recovery of its carrying value; and
|
•
|
in situations where there was not a previous OTTI for the investment, whether the current expected cash flows from the investment, primarily tax benefits, are less than those expected at the time the investment was acquired due to various factors, such as a change in the statutory tax rate; or
|
•
|
in situations where there was a previous OTTI for the investment, whether the expected cash flows from the investment at the time of the OTTI, primarily tax benefits, are less than its current carrying value.
|
|
Six Months Ended June 30
|
||||||||||
(In thousands)
|
2019
|
|
2018
|
|
Change
|
||||||
Net cash provided (used) by:
|
|
|
|
|
|
||||||
Operating activities
|
$
|
79,015
|
|
|
$
|
65,566
|
|
|
$
|
13,449
|
|
Investing activities
|
(2,720
|
)
|
|
277,898
|
|
|
(280,618
|
)
|
|||
Financing activities
|
(64,887
|
)
|
|
(411,244
|
)
|
|
346,357
|
|
|||
Increase (decrease) in cash and cash equivalents
|
$
|
11,408
|
|
|
$
|
(67,780
|
)
|
|
$
|
79,188
|
|
|
Six Months Ended June 30
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
Change
|
||||||
Net cash provided (used) by:
|
|
|
|
|
|
||||||
Operating activities
|
$
|
65,566
|
|
|
$
|
66,908
|
|
|
$
|
(1,342
|
)
|
Investing activities
|
277,898
|
|
|
242,177
|
|
|
35,721
|
|
|||
Financing activities
|
(411,244
|
)
|
|
(308,969
|
)
|
|
(102,275
|
)
|
|||
Increase (decrease) in cash and cash equivalents
|
$
|
(67,780
|
)
|
|
$
|
116
|
|
|
$
|
(67,896
|
)
|
|
Healthcare Professional Liability
|
|
Medical Technology & Life Sciences Products
|
|
Workers'
Compensation - Traditional
|
Per Occurrence Coverage
|
|
Aggregate Coverage (1)
|
•
|
Reinsurance is utilized on a per risk basis for the property insurance and casualty coverages in order to mitigate risk volatility.
|
•
|
Catastrophic protection is utilized on both our property insurance and casualty coverages to protect against losses in excess of policy limits as well as natural catastrophes.
|
•
|
Both quota share reinsurance and excess of loss reinsurance are utilized to manage the net loss exposure on our property reinsurance coverages.
|
•
|
Property umbrella excess of loss reinsurance is utilized for peak catastrophe and frequency of catastrophe exposures.
|
•
|
External excess of loss reinsurance is utilized by Syndicate 1729 to manage the net loss exposure on the specialty property and contingency coverages ceded to Syndicate 6131 (see further discussion in Segment Operating Results - Lloyd's Syndicates section that follows).
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||
($ in thousands)
|
Carrying
Value |
% of Total Investment
|
|
Carrying
Value |
% of Total Investment
|
||||||
Fixed maturities, available for sale
|
|
|
|
|
|
||||||
U.S. Treasury obligations
|
$
|
110,449
|
|
3
|
%
|
|
$
|
120,201
|
|
4
|
%
|
U.S. Government-sponsored enterprise obligations
|
29,147
|
|
1
|
%
|
|
35,354
|
|
1
|
%
|
||
State and municipal bonds
|
290,243
|
|
8
|
%
|
|
293,772
|
|
9
|
%
|
||
Corporate debt
|
1,306,864
|
|
38
|
%
|
|
1,223,475
|
|
37
|
%
|
||
Residential mortgage-backed securities
|
182,258
|
|
5
|
%
|
|
181,238
|
|
5
|
%
|
||
Commercial mortgage-backed securities
|
75,415
|
|
2
|
%
|
|
44,101
|
|
1
|
%
|
||
Other asset-backed securities
|
234,970
|
|
7
|
%
|
|
195,657
|
|
6
|
%
|
||
Total fixed maturities, available for sale
|
2,229,346
|
|
64
|
%
|
|
2,093,798
|
|
63
|
%
|
||
Fixed maturities, trading
|
43,156
|
|
1
|
%
|
|
38,188
|
|
1
|
%
|
||
Total fixed maturities
|
2,272,502
|
|
65
|
%
|
|
2,131,986
|
|
64
|
%
|
||
|
|
|
|
|
|
||||||
Equity investments
|
420,425
|
|
12
|
%
|
|
442,937
|
|
13
|
%
|
||
Short-term investments
|
287,009
|
|
9
|
%
|
|
308,319
|
|
9
|
%
|
||
BOLI
|
65,008
|
|
2
|
%
|
|
64,096
|
|
1
|
%
|
||
Investment in unconsolidated subsidiaries
|
385,631
|
|
11
|
%
|
|
367,757
|
|
11
|
%
|
||
Other investments
|
36,725
|
|
1
|
%
|
|
34,287
|
|
2
|
%
|
||
Total investments
|
$
|
3,467,300
|
|
100
|
%
|
|
$
|
3,349,382
|
|
100
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||
($ in thousands, except per share data)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||
Revenues:
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net premiums written
|
$
|
189,984
|
|
$
|
207,769
|
|
$
|
(17,785
|
)
|
|
|
$
|
435,725
|
|
$
|
422,901
|
|
$
|
12,824
|
|
|
Net premiums earned
|
$
|
209,149
|
|
$
|
223,591
|
|
$
|
(14,442
|
)
|
|
|
$
|
417,298
|
|
$
|
410,750
|
|
$
|
6,548
|
|
|
Net investment result
|
18,387
|
|
27,764
|
|
(9,377
|
)
|
|
|
40,395
|
|
51,430
|
|
(11,035
|
)
|
|
||||||
Net realized investment gains (losses)
|
9,308
|
|
2,795
|
|
6,513
|
|
|
|
45,931
|
|
(9,722
|
)
|
55,653
|
|
|
||||||
Other income
|
2,777
|
|
2,044
|
|
733
|
|
|
|
4,872
|
|
4,767
|
|
105
|
|
|
||||||
Total revenues
|
239,621
|
|
256,194
|
|
(16,573
|
)
|
|
|
508,496
|
|
457,225
|
|
51,271
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
Expenses:
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net losses and loss adjustment expenses
|
168,440
|
|
161,728
|
|
6,712
|
|
|
|
328,195
|
|
291,515
|
|
36,680
|
|
|
||||||
Underwriting, policy acquisition and operating expenses
|
62,708
|
|
59,611
|
|
3,097
|
|
|
|
124,100
|
|
116,969
|
|
7,131
|
|
|
||||||
Segregated portfolio cells dividend expense (income)
|
(7,033
|
)
|
2,785
|
|
(9,818
|
)
|
|
|
(2,246
|
)
|
4,532
|
|
(6,778
|
)
|
|
||||||
Interest expense
|
4,247
|
|
3,958
|
|
289
|
|
|
|
8,576
|
|
7,663
|
|
913
|
|
|
||||||
Total expenses
|
228,362
|
|
228,082
|
|
280
|
|
|
|
458,625
|
|
420,679
|
|
37,946
|
|
|
||||||
Income before income taxes
|
11,259
|
|
28,112
|
|
(16,853
|
)
|
|
|
49,871
|
|
36,546
|
|
13,325
|
|
|
||||||
Income tax expense (benefit)
|
(277
|
)
|
(311
|
)
|
34
|
|
|
|
6,685
|
|
(3,733
|
)
|
10,418
|
|
|
||||||
Net income
|
$
|
11,536
|
|
$
|
28,423
|
|
$
|
(16,887
|
)
|
|
|
$
|
43,186
|
|
$
|
40,279
|
|
$
|
2,907
|
|
|
Non-GAAP operating income
|
$
|
4,134
|
|
$
|
25,953
|
|
$
|
(21,819
|
)
|
|
|
$
|
8,298
|
|
$
|
47,440
|
|
$
|
(39,142
|
)
|
|
Earnings per share:
|
|
|
|
|
|
|
|
|
|
||||||||||||
Basic
|
$
|
0.21
|
|
$
|
0.53
|
|
$
|
(0.32
|
)
|
|
|
$
|
0.80
|
|
$
|
0.75
|
|
$
|
0.05
|
|
|
Diluted
|
$
|
0.21
|
|
$
|
0.53
|
|
$
|
(0.32
|
)
|
|
|
$
|
0.80
|
|
$
|
0.75
|
|
$
|
0.05
|
|
|
Non-GAAP operating earnings per share:
|
|
|
|
|
|
|
|
|
|
||||||||||||
Basic
|
$
|
0.08
|
|
$
|
0.48
|
|
$
|
(0.40
|
)
|
|
|
$
|
0.15
|
|
$
|
0.89
|
|
$
|
(0.74
|
)
|
|
Diluted
|
$
|
0.08
|
|
$
|
0.48
|
|
$
|
(0.40
|
)
|
|
|
$
|
0.15
|
|
$
|
0.88
|
|
$
|
(0.73
|
)
|
|
Net loss ratio
|
80.5
|
%
|
72.3
|
%
|
8.2
|
|
pts
|
|
78.6
|
%
|
71.0
|
%
|
7.6
|
|
pts
|
||||||
Underwriting expense ratio
|
30.0
|
%
|
26.7
|
%
|
3.3
|
|
pts
|
|
29.7
|
%
|
28.5
|
%
|
1.2
|
|
pts
|
||||||
Combined ratio
|
110.5
|
%
|
99.0
|
%
|
11.5
|
|
pts
|
|
108.3
|
%
|
99.5
|
%
|
8.8
|
|
pts
|
||||||
Operating ratio
|
99.2
|
%
|
89.0
|
%
|
10.2
|
|
pts
|
|
97.2
|
%
|
88.7
|
%
|
8.5
|
|
pts
|
||||||
Effective tax rate
|
(2.5
|
%)
|
(1.1
|
%)
|
(1.4
|
)
|
pts
|
|
13.4
|
%
|
(10.2
|
%)
|
23.6
|
|
pts
|
||||||
Return on equity*
|
2.9
|
%
|
7.2
|
%
|
(4.3
|
)
|
pts
|
|
5.6
|
%
|
5.1
|
%
|
0.5
|
|
pts
|
||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
* Annualized
|
|||||||||||||||||||||
In all tables that follow, the abbreviation "nm" indicates that the information or the percentage change is not meaningful.
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Net premiums earned
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Specialty P&C
|
$
|
126,011
|
|
|
$
|
142,619
|
|
|
$
|
(16,608
|
)
|
|
(11.6
|
%)
|
|
$
|
250,079
|
|
|
$
|
257,567
|
|
|
$
|
(7,488
|
)
|
|
(2.9
|
%)
|
Workers' Compensation Insurance
|
46,574
|
|
|
45,234
|
|
|
1,340
|
|
|
3.0
|
%
|
|
92,512
|
|
|
87,934
|
|
|
4,578
|
|
|
5.2
|
%
|
||||||
Segregated Portfolio Cell Reinsurance
|
19,284
|
|
|
18,248
|
|
|
1,036
|
|
|
5.7
|
%
|
|
38,787
|
|
|
35,284
|
|
|
3,503
|
|
|
9.9
|
%
|
||||||
Lloyd's Syndicates
|
17,280
|
|
|
17,490
|
|
|
(210
|
)
|
|
(1.2
|
%)
|
|
35,920
|
|
|
29,965
|
|
|
5,955
|
|
|
19.9
|
%
|
||||||
Consolidated total
|
$
|
209,149
|
|
|
$
|
223,591
|
|
|
$
|
(14,442
|
)
|
|
(6.5
|
%)
|
|
$
|
417,298
|
|
|
$
|
410,750
|
|
|
$
|
6,548
|
|
|
1.6
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Net investment income
|
$
|
23,539
|
|
|
$
|
22,384
|
|
|
$
|
1,155
|
|
|
5.2
|
%
|
|
$
|
46,357
|
|
|
$
|
44,411
|
|
|
$
|
1,946
|
|
|
4.4
|
%
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
(5,152
|
)
|
|
5,380
|
|
|
(10,532
|
)
|
|
(195.8
|
%)
|
|
(5,962
|
)
|
|
7,019
|
|
|
(12,981
|
)
|
|
(184.9
|
%)
|
||||||
Net investment result
|
$
|
18,387
|
|
|
$
|
27,764
|
|
|
$
|
(9,377
|
)
|
|
(33.8
|
%)
|
|
$
|
40,395
|
|
|
$
|
51,430
|
|
|
$
|
(11,035
|
)
|
|
(21.5
|
%)
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Net impairment losses recognized in earnings
|
$
|
—
|
|
|
$
|
(404
|
)
|
|
$
|
404
|
|
|
nm
|
|
|
$
|
(49
|
)
|
|
$
|
(404
|
)
|
|
$
|
355
|
|
|
87.9
|
%
|
Other net realized investment gains (losses)
|
9,308
|
|
|
3,199
|
|
|
6,109
|
|
|
191.0
|
%
|
|
45,980
|
|
|
(9,318
|
)
|
|
55,298
|
|
|
593.5
|
%
|
||||||
Net realized investment gains (losses)
|
$
|
9,308
|
|
|
$
|
2,795
|
|
|
$
|
6,513
|
|
|
233.0
|
%
|
|
$
|
45,931
|
|
|
$
|
(9,722
|
)
|
|
$
|
55,653
|
|
|
572.4
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||
($ in millions)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||
Current accident year net loss ratio
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Consolidated ratio
|
88.2
|
%
|
|
82.5
|
%
|
|
5.7
|
|
pts
|
|
84.9
|
%
|
|
82.1
|
%
|
|
2.8
|
|
pts
|
||||||
Specialty P&C
|
94.0
|
%
|
|
91.8
|
%
|
|
2.2
|
|
pts
|
|
93.6
|
%
|
|
91.2
|
%
|
|
2.4
|
|
pts
|
||||||
Workers' Compensation Insurance
|
68.2
|
%
|
|
67.0
|
%
|
|
1.2
|
|
pts
|
|
68.2
|
%
|
|
66.5
|
%
|
|
1.7
|
|
pts
|
||||||
Segregated Portfolio Cell Reinsurance
|
115.2
|
%
|
|
66.1
|
%
|
|
49.1
|
|
pts
|
|
90.8
|
%
|
|
66.7
|
%
|
|
24.1
|
|
pts
|
||||||
Lloyd's Syndicates
|
69.7
|
%
|
|
64.2
|
%
|
|
5.5
|
|
pts
|
|
61.8
|
%
|
|
66.9
|
%
|
|
(5.1
|
)
|
pts
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Calendar year net loss ratio
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Consolidated ratio
|
80.5
|
%
|
|
72.3
|
%
|
|
8.2
|
|
pts
|
|
78.6
|
%
|
|
71.0
|
%
|
|
7.6
|
|
pts
|
||||||
Specialty P&C
|
84.1
|
%
|
|
77.7
|
%
|
|
6.4
|
|
pts
|
|
85.4
|
%
|
|
75.5
|
%
|
|
9.9
|
|
pts
|
||||||
Workers' Compensation Insurance
|
65.8
|
%
|
|
64.8
|
%
|
|
1.0
|
|
pts
|
|
66.0
|
%
|
|
65.0
|
%
|
|
1.0
|
|
pts
|
||||||
Segregated Portfolio Cell Reinsurance
|
103.6
|
%
|
|
49.6
|
%
|
|
54.0
|
|
pts
|
|
79.2
|
%
|
|
53.9
|
%
|
|
25.3
|
|
pts
|
||||||
Lloyd's Syndicates
|
68.4
|
%
|
|
71.5
|
%
|
|
(3.1
|
)
|
pts
|
|
63.3
|
%
|
|
70.1
|
%
|
|
(6.8
|
)
|
pts
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Favorable (unfavorable) net loss development, prior accident years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Consolidated
|
$
|
16.0
|
|
|
$
|
22.8
|
|
|
$
|
(6.8
|
)
|
|
|
$
|
26.3
|
|
|
$
|
45.6
|
|
|
$
|
(19.3
|
)
|
|
Specialty P&C
|
$
|
12.4
|
|
|
$
|
20.1
|
|
|
$
|
(7.7
|
)
|
|
|
$
|
20.3
|
|
|
$
|
40.6
|
|
|
$
|
(20.3
|
)
|
|
Workers' Compensation Insurance
|
$
|
1.1
|
|
|
$
|
1.0
|
|
|
$
|
0.1
|
|
|
|
$
|
2.0
|
|
|
$
|
1.4
|
|
|
$
|
0.6
|
|
|
Segregated Portfolio Cell Reinsurance
|
$
|
2.3
|
|
|
$
|
3.0
|
|
|
$
|
(0.7
|
)
|
|
|
$
|
4.5
|
|
|
$
|
4.5
|
|
|
$
|
—
|
|
|
Lloyd's Syndicates
|
$
|
0.2
|
|
|
$
|
(1.3
|
)
|
|
$
|
1.5
|
|
|
|
$
|
(0.5
|
)
|
|
$
|
(0.9
|
)
|
|
$
|
0.4
|
|
|
|
Three Months Ended June 30
|
||||||||||||||||||
|
2019
|
|
2018
|
|
Change
|
||||||||||||||
|
As reported
|
E&O reserve impact
|
Adjusted
|
|
As reported
|
LPT impact
|
Adjusted
|
|
As reported
|
Adjusted
|
|||||||||
Calendar year net loss ratio
|
80.5
|
%
|
4.7
|
pts
|
75.8
|
%
|
|
72.3
|
%
|
3.3
|
pts
|
69.0
|
%
|
|
8.2
|
|
pts
|
6.8
|
pts
|
Less impact of prior accident years on the net loss ratio
|
(7.7
|
%)
|
—
|
pts
|
(7.7
|
%)
|
|
(10.2
|
%)
|
1.4
|
pts
|
(11.6
|
%)
|
|
2.5
|
|
pts
|
3.9
|
pts
|
Current accident year net loss ratio
|
88.2
|
%
|
4.7
|
pts
|
83.5
|
%
|
|
82.5
|
%
|
1.9
|
pts
|
80.6
|
%
|
|
5.7
|
|
pts
|
2.9
|
pts
|
|
|||||||||||||||||||
|
Six Months Ended June 30
|
||||||||||||||||||
|
2019
|
|
2018
|
|
Change
|
||||||||||||||
|
As reported
|
E&O reserve impact
|
Adjusted
|
|
As reported
|
LPT impact
|
Adjusted
|
|
As reported
|
Adjusted
|
|||||||||
Calendar year net loss ratio
|
78.6
|
%
|
2.3
|
pts
|
76.3
|
%
|
|
71.0
|
%
|
1.8
|
pts
|
69.2
|
%
|
|
7.6
|
|
pts
|
7.1
|
pts
|
Less impact of prior accident years on the net loss ratio
|
(6.3
|
%)
|
—
|
pts
|
(6.3
|
%)
|
|
(11.1
|
%)
|
0.8
|
pts
|
(11.9
|
%)
|
|
4.8
|
|
pts
|
5.6
|
pts
|
Current accident year net loss ratio
|
84.9
|
%
|
2.3
|
pts
|
82.6
|
%
|
|
82.1
|
%
|
1.0
|
pts
|
81.1
|
%
|
|
2.8
|
|
pts
|
1.5
|
pts
|
|
Six Months Ended June 30
|
||||
|
2019
|
|
2018
|
||
Projected annual effective tax rate
|
(39.0
|
%)
|
|
(3.2
|
%)
|
Tax effect of discrete items
|
52.4
|
%
|
|
(7.0
|
%)
|
Total effective tax rate
|
13.4
|
%
|
|
(10.2
|
%)
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
|||||||||||
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
|||||||
ROE
|
2.9
|
%
|
7.2
|
%
|
(4.3
|
)
|
pts
|
|
5.6
|
%
|
5.1
|
%
|
0.5
|
pts
|
|
Book Value Per Share
|
||
Book Value Per Share at December 31, 2018
|
$
|
28.39
|
|
Increase (decrease) to book value per share during the six months ended June 30, 2019 attributable to:
|
|
||
Dividends declared
|
(0.62
|
)
|
|
Net income
|
0.80
|
|
|
OCI
|
0.91
|
|
|
Other *
|
(0.06
|
)
|
|
Book Value Per Share at June 30, 2019
|
$
|
29.42
|
|
* Includes the impact of cumulative effect adjustments related to ASUs adopted during 2019.
|
|
Three Months Ended
June 30 |
|
Six Months Ended
June 30 |
||||||||||||
(In thousands, except per share data)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Net income
|
$
|
11,536
|
|
|
$
|
28,423
|
|
|
$
|
43,186
|
|
|
$
|
40,279
|
|
Items excluded in the calculation of Non-GAAP operating income:
|
|
|
|
|
|
|
|
||||||||
Net realized investment (gains) losses
|
(9,308
|
)
|
|
(2,795
|
)
|
|
(45,931
|
)
|
|
9,722
|
|
||||
Net realized gains (losses) attributable to SPCs which no profit/loss is retained (1)
|
(79
|
)
|
|
(334
|
)
|
|
1,663
|
|
|
(744
|
)
|
||||
Guaranty fund assessments (recoupments)
|
18
|
|
|
3
|
|
|
106
|
|
|
87
|
|
||||
Pre-tax effect of exclusions
|
(9,369
|
)
|
|
(3,126
|
)
|
|
(44,162
|
)
|
|
9,065
|
|
||||
Tax effect, at 21% (2)
|
1,967
|
|
|
656
|
|
|
9,274
|
|
|
(1,904
|
)
|
||||
After-tax effect of exclusions
|
(7,402
|
)
|
|
(2,470
|
)
|
|
(34,888
|
)
|
|
7,161
|
|
||||
Non-GAAP operating income
|
$
|
4,134
|
|
|
$
|
25,953
|
|
|
$
|
8,298
|
|
|
$
|
47,440
|
|
Per diluted common share:
|
|
|
|
|
|
|
|
||||||||
Net income
|
$
|
0.21
|
|
|
$
|
0.53
|
|
|
$
|
0.80
|
|
|
$
|
0.75
|
|
Effect of exclusions
|
(0.13
|
)
|
|
(0.05
|
)
|
|
(0.65
|
)
|
|
0.13
|
|
||||
Non-GAAP operating income per diluted common share
|
$
|
0.08
|
|
|
$
|
0.48
|
|
|
$
|
0.15
|
|
|
$
|
0.88
|
|
(1) Net realized investment gains (losses) on investments related to SPCs are recognized in our Segregated Portfolio Cell Reinsurance segment and the portion of operating earnings, including the gain or loss, net of our participation, is due to the external cell participants through the SPC dividend expense (income). To be consistent with our exclusion of net realized investment gains (losses) recognized in earnings, we are excluding the portion of net realized investment gains (losses) that is included in the SPC dividend expense (income) which is due to the external cell participants.
|
|||||||||||||||
(2) The 21% rate is the annual expected statutory tax rate associated with the taxable or tax deductible items listed above. Excluding net realized investment (gains) losses, which are discrete items and are tax effected at the annual expected statutory tax rate in the period they are included in net income, our effective tax rate for the respective periods was applied to these items in calculating net income. See previous discussion in this section under the heading "Taxes."
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||||||
Net premiums written
|
$
|
111,253
|
|
$
|
131,833
|
|
$
|
(20,580
|
)
|
|
(15.6
|
%)
|
|
$
|
251,909
|
|
$
|
250,679
|
|
$
|
1,230
|
|
|
0.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Net premiums earned
|
$
|
126,011
|
|
$
|
142,619
|
|
$
|
(16,608
|
)
|
|
(11.6
|
%)
|
|
$
|
250,079
|
|
$
|
257,567
|
|
$
|
(7,488
|
)
|
|
(2.9
|
%)
|
Other income
|
1,470
|
|
1,262
|
|
208
|
|
|
16.5
|
%
|
|
2,680
|
|
2,519
|
|
161
|
|
|
6.4
|
%
|
||||||
Net losses and loss adjustment expenses
|
(106,017
|
)
|
(110,856
|
)
|
4,839
|
|
|
(4.4
|
%)
|
|
(213,675
|
)
|
(194,380
|
)
|
(19,295
|
)
|
|
9.9
|
%
|
||||||
Underwriting, policy acquisition and operating expenses
|
(29,863
|
)
|
(27,922
|
)
|
(1,941
|
)
|
|
7.0
|
%
|
|
(59,480
|
)
|
(55,902
|
)
|
(3,578
|
)
|
|
6.4
|
%
|
||||||
Segment operating results
|
$
|
(8,399
|
)
|
$
|
5,103
|
|
$
|
(13,502
|
)
|
|
(264.6
|
%)
|
|
$
|
(20,396
|
)
|
$
|
9,804
|
|
$
|
(30,200
|
)
|
|
(308.0
|
%)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Net loss ratio
|
84.1%
|
77.7%
|
6.4
|
|
pts
|
85.4
|
%
|
75.5
|
%
|
9.9
|
|
pts
|
|||||||||||||
Underwriting expense ratio
|
23.7%
|
19.6%
|
4.1
|
|
pts
|
23.8
|
%
|
21.7
|
%
|
2.1
|
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Gross premiums written
|
$
|
127,901
|
|
|
$
|
147,978
|
|
|
$
|
(20,077
|
)
|
|
(13.6
|
%)
|
|
$
|
294,333
|
|
|
$
|
288,498
|
|
|
$
|
5,835
|
|
|
2.0
|
%
|
Less: Ceded premiums written
|
16,648
|
|
|
16,145
|
|
|
503
|
|
|
3.1
|
%
|
|
42,424
|
|
|
37,819
|
|
|
4,605
|
|
|
12.2
|
%
|
||||||
Net premiums written
|
$
|
111,253
|
|
|
$
|
131,833
|
|
|
$
|
(20,580
|
)
|
|
(15.6
|
%)
|
|
$
|
251,909
|
|
|
$
|
250,679
|
|
|
$
|
1,230
|
|
|
0.5
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Professional liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Physicians (1)(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Twelve month term
|
$
|
73,309
|
|
|
$
|
75,920
|
|
|
$
|
(2,611
|
)
|
|
(3.4
|
%)
|
|
$
|
181,097
|
|
|
$
|
163,764
|
|
|
$
|
17,333
|
|
|
10.6
|
%
|
Twenty-four month term
|
10,081
|
|
|
4,572
|
|
|
5,509
|
|
|
120.5
|
%
|
|
16,686
|
|
|
12,821
|
|
|
3,865
|
|
|
30.1
|
%
|
||||||
Total Physicians
|
83,390
|
|
|
80,492
|
|
|
2,898
|
|
|
3.6
|
%
|
|
197,783
|
|
|
176,585
|
|
|
21,198
|
|
|
12.0
|
%
|
||||||
Healthcare facilities (2)(8)
|
14,068
|
|
|
14,051
|
|
|
17
|
|
|
0.1
|
%
|
|
36,288
|
|
|
29,134
|
|
|
7,154
|
|
|
24.6
|
%
|
||||||
Other healthcare providers (3)
|
7,331
|
|
|
6,792
|
|
|
539
|
|
|
7.9
|
%
|
|
17,282
|
|
|
15,783
|
|
|
1,499
|
|
|
9.5
|
%
|
||||||
Legal professionals (4)
|
6,745
|
|
|
6,663
|
|
|
82
|
|
|
1.2
|
%
|
|
14,815
|
|
|
14,462
|
|
|
353
|
|
|
2.4
|
%
|
||||||
Tail coverages (5)(6)
|
4,752
|
|
|
11,422
|
|
|
(6,670
|
)
|
|
(58.4
|
%)
|
|
9,181
|
|
|
15,771
|
|
|
(6,590
|
)
|
|
(41.8
|
%)
|
||||||
Retroactive coverages (6)
|
—
|
|
|
18,708
|
|
|
(18,708
|
)
|
|
nm
|
|
|
—
|
|
|
18,708
|
|
|
(18,708
|
)
|
|
nm
|
|
||||||
Total professional liability
|
116,286
|
|
|
138,128
|
|
|
(21,842
|
)
|
|
(15.8
|
%)
|
|
275,349
|
|
|
270,443
|
|
|
4,906
|
|
|
1.8
|
%
|
||||||
Medical technology liability (7)
|
9,937
|
|
|
9,723
|
|
|
214
|
|
|
2.2
|
%
|
|
17,140
|
|
|
17,821
|
|
|
(681
|
)
|
|
(3.8
|
%)
|
||||||
Other (9)
|
1,678
|
|
|
127
|
|
|
1,551
|
|
|
1,221.3
|
%
|
|
1,844
|
|
|
234
|
|
|
1,610
|
|
|
688.0
|
%
|
||||||
Total
|
$
|
127,901
|
|
|
$
|
147,978
|
|
|
$
|
(20,077
|
)
|
|
(13.6
|
%)
|
|
$
|
294,333
|
|
|
$
|
288,498
|
|
|
$
|
5,835
|
|
|
2.0
|
%
|
(1)
|
Physician policies were our greatest source of premium revenues in both 2019 and 2018. The decrease in twelve month term policies during the 2019 three-month period was primarily driven by retention losses, partially offset by new business written, including the addition of one large policy, an increase in renewal pricing and, to a lesser extent, timing differences of $0.8 million primarily related to the shifting in renewal dates of a few large policies. The increase in twelve month term policies during the 2019 six-month period included timing differences of $7.6 million primarily related to the renewal of a few large policies that shifted their 2018 renewal dates to the first quarter of 2019. Excluding the effect of these timing differences, twelve month term policies increased approximately $9.7 million as compared to the same period of 2018. The remaining increase during the 2019 six-month period was due to new business written, including the addition of three large policies totaling $10.3 million, and an increase in renewal pricing, partially offset by retention losses. Additionally, both the 2019 three- and six- month periods included an increase in premiums assumed in which we participate on a quota share basis. Renewal pricing increases in both periods are reflective of our concern about potential increases in loss severity, and the lower retention is largely attributable to the corresponding increase in price competition. We anticipate a lower than average level of retention to persist as we continue to set our rates to reflect our observations of potentially higher severity trends. We also offer twenty-four month term policies to our physician insureds in one selected jurisdiction. The increase in twenty-four month term policies during the 2019 three- and six- month periods, as compared to the same respective periods in 2018, primarily reflected the normal cycle of renewals (policies subject to renewal in 2019 were previously written in 2017 rather than in 2018).
|
(2)
|
Our healthcare facilities premium (which includes hospitals, surgery centers and other similar facilities) remained relatively flat during the 2019 three-month period as compared to the same period of 2018. The increase in the 2019 six-month period was driven by new business written, including three large policies totaling $4.1 million, and renewal pricing increases, partially offset by retention losses. Renewal pricing increases are primarily due to changes in the loss experience of a few large policies as well as more moderate marketplace price competition. Additionally, given the loss environment and initial loss indications we are seeing in the healthcare facilities space, we are seeking rate increases where we believe appropriate. The lower retention rate in the 2019 six-month period is primarily driven by the loss of one large policy in the first quarter of 2019 due to price competition.
|
(3)
|
Our other healthcare providers are primarily dentists, chiropractors and allied health professionals.
|
(4)
|
Our legal professionals policies are primarily individual and small group policies in select areas of practice. The increase during the 2019 three- and six- month periods was driven by new business written and, to a lesser extent, an increase in the rate charged for certain renewed policies in select states due to rate filings, largely offset by retention losses.
|
(5)
|
We offer extended reporting endorsement or "tail" coverage to insureds who discontinue their claims-made coverage with us, and we also periodically offer tail coverage through custom policies. The amount of tail coverage premium written can vary significantly from period to period. The decrease in tail premiums during the 2019 three- and six- month periods as
|
(6)
|
We offer custom alternative risk solutions including loss portfolio transfers for large healthcare entities who, most commonly, are exiting a line of business, changing an insurance approach or simply preferring to transfer risk. In the second quarter of 2018, we entered into a loss portfolio transfer with a large healthcare organization to cover a specific inventory of existing claims as well as provide tail coverage. The premiums received for the coverage provided for the existing inventory of claims was classified as retroactive coverage and resulted in $18.7 million of one-time premium written and fully earned in the 2018 three- and six- month periods. The premiums received for the prospective (tail) coverage resulted in $7.9 million of one-time premium written and fully earned in the 2018 three- and six- month periods. See Note 4 of the Notes to the Condensed Consolidated Financial Statements for further information on this transaction.
|
(7)
|
Our medical technology liability business is marketed throughout the U.S.; coverage is typically offered on a primary basis, within specified limits, to manufacturers and distributors of medical technology and life sciences products including entities conducting human clinical trials. In addition to the previously listed factors that affect our premium volume, our medical technology liability premium volume is impacted by the sales volume of insureds. The increase during the 2019 three-month period was driven by new business written and, to a lesser extent, an increase in renewal pricing, largely offset by retention losses. The decrease during the 2019 six-month period was primarily due to retention losses, partially offset by new business written and, to a lesser extent, an increase in renewal pricing. The increase in renewal pricing during both the 2019 three- and six- month periods was primarily due to an increase in the sales volume of certain insureds. Retention losses in the 2019 three- and six- month periods are largely attributable to an increase in competition on terms and pricing.
|
(8)
|
Certain components of our gross premiums written include alternative market premiums. We cede either all or a portion of the alternative market premium, net of reinsurance, to certain SPCs of our wholly owned Cayman Islands reinsurance subsidiaries, Inova Re and Eastern Re, which are reported in our Segregated Portfolio Cell Reinsurance segment (see further discussion in the Ceded Premiums Written section that follows). The portion not ceded to the SPCs is retained within our Specialty P&C segment. Alternative market gross premiums written by component for the 2019 and 2018 three- and six- month periods were as follows:
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in millions)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Physicians
|
$
|
1.4
|
|
|
$
|
1.3
|
|
|
$
|
0.1
|
|
|
7.7
|
%
|
|
$
|
1.4
|
|
|
$
|
1.4
|
|
|
$
|
—
|
|
|
—
|
%
|
Healthcare facilities
|
0.2
|
|
|
0.4
|
|
|
(0.2
|
)
|
|
(50.0
|
%)
|
|
3.9
|
|
|
3.6
|
|
|
0.3
|
|
|
8.3
|
%
|
||||||
Total
|
$
|
1.6
|
|
|
$
|
1.7
|
|
|
$
|
(0.1
|
)
|
|
(5.9
|
%)
|
|
$
|
5.3
|
|
|
$
|
5.0
|
|
|
$
|
0.3
|
|
|
6.0
|
%
|
(9)
|
This component of gross premiums written includes all other product lines within our Specialty P&C segment. The increase during the 2019 three- and six- month periods was due to a $1.5 million specialty contractual liability policy.
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
(In millions)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Physicians
|
$
|
3.1
|
|
|
$
|
3.7
|
|
|
$
|
17.5
|
|
|
$
|
8.7
|
|
Healthcare facilities
|
2.6
|
|
|
2.2
|
|
|
6.9
|
|
|
4.3
|
|
||||
Other healthcare providers
|
0.3
|
|
|
0.3
|
|
|
0.7
|
|
|
1.7
|
|
||||
Legal professionals
|
0.8
|
|
|
0.9
|
|
|
1.7
|
|
|
1.7
|
|
||||
Medical technology liability
|
1.3
|
|
|
0.9
|
|
|
2.2
|
|
|
1.8
|
|
||||
Total
|
$
|
8.1
|
|
|
$
|
8.0
|
|
|
$
|
29.0
|
|
|
$
|
18.2
|
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||||
Excess of loss reinsurance arrangements (1)
|
$
|
8,661
|
|
$
|
8,815
|
|
$
|
(154
|
)
|
(1.7
|
%)
|
|
$
|
17,982
|
|
$
|
17,738
|
|
$
|
244
|
|
1.4
|
%
|
Premium ceded to Syndicate 1729 (2)
|
—
|
|
—
|
|
—
|
|
—
|
%
|
|
—
|
|
2,105
|
|
(2,105
|
)
|
nm
|
|
||||||
Other shared risk arrangements (3)
|
6,135
|
|
6,352
|
|
(217
|
)
|
(3.4
|
%)
|
|
17,853
|
|
14,865
|
|
2,988
|
|
20.1
|
%
|
||||||
Premium ceded to SPCs (4)
|
1,152
|
|
1,399
|
|
(247
|
)
|
(17.7
|
%)
|
|
4,890
|
|
4,517
|
|
373
|
|
8.3
|
%
|
||||||
Other ceded premiums written
|
700
|
|
713
|
|
(13
|
)
|
(1.8
|
%)
|
|
1,699
|
|
1,653
|
|
46
|
|
2.8
|
%
|
||||||
Adjustment to premiums owed under reinsurance agreements, prior accident years, net (5)
|
—
|
|
(1,134
|
)
|
1,134
|
|
nm
|
|
|
—
|
|
(3,059
|
)
|
3,059
|
|
nm
|
|
||||||
Total ceded premiums written
|
$
|
16,648
|
|
$
|
16,145
|
|
$
|
503
|
|
3.1
|
%
|
|
$
|
42,424
|
|
$
|
37,819
|
|
$
|
4,605
|
|
12.2
|
%
|
(1)
|
We generally reinsure risks under our excess of loss reinsurance arrangements pursuant to which the reinsurers agree to assume all or a portion of all risks that we insure above our individual risk retention levels, up to the maximum individual limits offered. In the majority of our excess of loss reinsurance arrangements, the premium due to the reinsurer is determined by the loss experience of that business reinsured, subject to certain minimum and maximum amounts. Premium due to reinsurers also fluctuates with the volume of written premium subject to cession under the arrangement. For the 2019 three- and six- month periods, the change in ceded premiums written under our excess of loss reinsurance arrangements primarily reflected changes in the overall volume of gross premiums written subject to cession.
|
(2)
|
Prior to January 1, 2018, our Specialty P&C segment ceded premiums to Syndicate 1729 under a quota share reinsurance agreement. We record our participation in Syndicate 1729 in our Lloyd's Syndicates segment on a quarter delay, except when information is material to the current period. We also recorded the cession to Syndicate 1729 from our Specialty P&C segment on the same quarter delay as the amounts were not material and that permitted the cession to be reported by both our Lloyd's Syndicates segment and our Specialty P&C segment in the same reporting period. The decrease in premiums ceded to Syndicate 1729 during the 2019 six-month period is due to the non-renewal of the quota share reinsurance agreement with Syndicate 1729 on January 1, 2018; the impact of which was not reflected in ceded premiums written until the second quarter of 2018 due to the previously mentioned quarter delay. See the Segment Operating Results - Lloyd's Syndicates section for further discussion on the quota share agreement.
|
(3)
|
We have entered into various shared risk arrangements, including quota share, fronting, and captive arrangements, with certain large healthcare systems and other insurance entities. These arrangements include our Ascension Health and CAPAssurance programs. While we cede a large portion of the premium written under these arrangements, they provide us an opportunity to grow net premium through strategic partnerships. For the 2019 three-month period, the decrease in ceded premiums written under our shared risk arrangements was primarily due to a decrease in premium ceded to our Ascension Health program. For the 2019 six-month period, the increase in ceded premiums written under our shared risk arrangements was primarily driven by growth in our CAPAssurance program.
|
(4)
|
As previously discussed, as a part of our alternative market solutions, all or a portion of certain healthcare premium written is ceded to SPCs in our Segregated Portfolio Cell Reinsurance segment under either excess of loss or quota share reinsurance agreements, depending on the structure of the individual program. See the Segment Operating Results - Segregated Portfolio Cell Reinsurance section for further discussion on the cession to the SPCs from our Specialty P&C segment. Premiums ceded to SPCs during the 2019 three- and six- month periods remained relatively unchanged as compared to the same periods of 2018.
|
(5)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance arrangement are known. As a part of the process of estimating our loss reserve we also make estimates regarding the amounts recoverable under our reinsurance arrangements. As previously discussed, the premiums ultimately ceded under certain of our excess of loss reinsurance arrangements are subject to the losses ceded under the arrangements. As part of the review of our reserves during both the 2019 three- and six- month periods, we concluded that our current estimate of expected losses and associated recoveries for prior year ceded losses was reasonable; therefore, we did not adjust our estimate of ceded premiums owed to reinsurers during the 2019 three- and six- month periods. For the 2018 three- and six- month periods, we reduced our estimate of expected losses and associated recoveries for prior year ceded losses, as well as our estimate of ceded premiums owed to reinsurers. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the changes in estimates occur.
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
|
2019
|
|
2018
|
Change
|
|
2019
|
|
2018
|
Change
|
||||||
Ceded premiums ratio, as reported
|
13.0
|
%
|
|
10.9
|
%
|
2.1
|
pts
|
|
14.4
|
%
|
|
13.1
|
%
|
1.3
|
pts
|
Less the effect of adjustments in premiums owed under reinsurance agreements, prior accident years (as previously discussed)
|
—
|
%
|
|
(0.8
|
%)
|
0.8
|
pts
|
|
—
|
%
|
|
(1.1
|
%)
|
1.1
|
pts
|
Ratio, current accident year
|
13.0
|
%
|
|
11.7
|
%
|
1.3
|
pts
|
|
14.4
|
%
|
|
14.2
|
%
|
0.2
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Gross premiums earned
|
$
|
145,169
|
|
|
$
|
161,596
|
|
|
$
|
(16,427
|
)
|
|
(10.2
|
%)
|
|
$
|
288,186
|
|
|
$
|
295,294
|
|
|
$
|
(7,108
|
)
|
|
(2.4
|
%)
|
Less: Ceded premiums earned
|
19,158
|
|
|
18,977
|
|
|
181
|
|
|
1.0
|
%
|
|
38,107
|
|
|
37,727
|
|
|
380
|
|
|
1.0
|
%
|
||||||
Net premiums earned
|
$
|
126,011
|
|
|
$
|
142,619
|
|
|
$
|
(16,608
|
)
|
|
(11.6
|
%)
|
|
$
|
250,079
|
|
|
$
|
257,567
|
|
|
$
|
(7,488
|
)
|
|
(2.9
|
%)
|
|
Net Loss Ratios (1)
|
|||||||||||||
|
Three Months Ended June 30
|
|||||||||||||
|
2019
|
|
2018
|
|
Change
|
|||||||||
|
As reported
|
|
As reported
|
LPT impact
|
Adjusted
|
|
As reported
|
Adjusted
|
||||||
Calendar year net loss ratio
|
84.1
|
%
|
|
77.7
|
%
|
4.3
|
pts
|
73.4
|
%
|
|
6.4
|
pts
|
10.7
|
pts
|
Less impact of prior accident years on the net loss ratio
|
(9.9
|
%)
|
|
(14.1
|
%)
|
3.2
|
pts
|
(17.3
|
%)
|
|
4.2
|
pts
|
7.4
|
pts
|
Current accident year net loss ratio
|
94.0
|
%
|
|
91.8
|
%
|
1.1
|
pts
|
90.7
|
%
|
|
2.2
|
pts
|
3.3
|
pts
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
|
|
|
|
|
|||
Ceded premium adjustments, prior accident years (2)
|
—
|
%
|
|
(0.7
|
%)
|
0.3
|
pts
|
(1.0
|
%)
|
|
0.7
|
pts
|
1.0
|
pts
|
Current accident year net loss ratio, excluding the effect of prior year ceded premium (3)
|
94.0
|
%
|
|
92.5
|
%
|
0.8
|
pts
|
91.7
|
%
|
|
1.5
|
pts
|
2.3
|
pts
|
|
Net Loss Ratios (1)
|
|||||||||||||
|
Six Months Ended June 30
|
|||||||||||||
|
2019
|
|
2018
|
|
Change
|
|||||||||
|
As reported
|
|
As reported
|
LPT impact
|
Adjusted
|
|
As reported
|
Adjusted
|
||||||
Calendar year net loss ratio
|
85.4
|
%
|
|
75.5
|
%
|
2.5
|
pts
|
73.0
|
%
|
|
9.9
|
pts
|
12.4
|
pts
|
Less impact of prior accident years on the net loss ratio
|
(8.2
|
%)
|
|
(15.7
|
%)
|
1.9
|
pts
|
(17.6
|
%)
|
|
7.5
|
pts
|
9.4
|
pts
|
Current accident year net loss ratio
|
93.6
|
%
|
|
91.2
|
%
|
0.6
|
pts
|
90.6
|
%
|
|
2.4
|
pts
|
3.0
|
pts
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
|
|
|
|
|
|||
Ceded premium adjustments, prior accident years (2)
|
—
|
%
|
|
(1.1
|
%)
|
0.2
|
pts
|
(1.3
|
%)
|
|
1.1
|
pts
|
1.3
|
pts
|
Current accident year net loss ratio, excluding the effect of prior year ceded premium (3)
|
93.6
|
%
|
|
92.3
|
%
|
0.4
|
pts
|
91.9
|
%
|
|
1.3
|
pts
|
1.7
|
pts
|
(1)
|
Net losses, as specified, divided by net premiums earned.
|
(2)
|
Reductions to premiums owed under reinsurance agreements for prior accident years increased net premiums earned (the denominator of the current accident year ratio) for the 2018 three- and six- month periods. No such adjustments were made during the 2019 three- and six- month periods. See the discussion in the Premiums section for our Specialty P&C segment under the heading "Ceded Premiums Written" for additional information.
|
(3)
|
The current accident year net loss ratio for the 2019 three- and six- month periods, excluding the effect of the 2018 loss portfolio transfer and prior year ceded premium adjustments, as shown in the table above, was higher as compared to the same periods of 2018 due to our continued concern around potential loss trends in the broader HCPL industry. Furthermore, the increase in the current accident year net loss ratio during the 2019 three- and six- month periods was due to changes in the mix of business including a higher volume of earned premium in our excess and surplus lines of business, which carries a higher loss ratio as compared to the segment's total book of business.
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
DPAC amortization
|
$
|
14,444
|
|
|
$
|
13,246
|
|
|
$
|
1,198
|
|
|
9.0
|
%
|
|
$
|
28,535
|
|
|
$
|
25,983
|
|
|
$
|
2,552
|
|
|
9.8
|
%
|
Management fees
|
1,474
|
|
|
1,789
|
|
|
(315
|
)
|
|
(17.6
|
%)
|
|
3,440
|
|
|
3,486
|
|
|
(46
|
)
|
|
(1.3
|
%)
|
||||||
Other underwriting and operating expenses
|
13,945
|
|
|
12,887
|
|
|
1,058
|
|
|
8.2
|
%
|
|
27,505
|
|
|
26,433
|
|
|
1,072
|
|
|
4.1
|
%
|
||||||
Total
|
$
|
29,863
|
|
|
$
|
27,922
|
|
|
$
|
1,941
|
|
|
7.0
|
%
|
|
$
|
59,480
|
|
|
$
|
55,902
|
|
|
$
|
3,578
|
|
|
6.4
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||
Underwriting expense ratio
|
23.7
|
%
|
|
19.6
|
%
|
|
4.1
|
pts
|
|
23.8
|
%
|
|
21.7
|
%
|
|
2.1
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||||
Net premiums written
|
$
|
45,031
|
|
$
|
49,155
|
|
$
|
(4,124
|
)
|
(8.4
|
%)
|
|
$
|
96,438
|
|
$
|
104,637
|
|
$
|
(8,199
|
)
|
(7.8
|
%)
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Net premiums earned
|
$
|
46,574
|
|
$
|
45,234
|
|
$
|
1,340
|
|
3.0
|
%
|
|
$
|
92,512
|
|
$
|
87,934
|
|
$
|
4,578
|
|
5.2
|
%
|
Other income
|
725
|
|
602
|
|
123
|
|
20.4
|
%
|
|
1,454
|
|
1,453
|
|
1
|
|
0.1
|
%
|
||||||
Net losses and loss adjustment expenses
|
(30,625
|
)
|
(29,319
|
)
|
(1,306
|
)
|
4.5
|
%
|
|
(61,068
|
)
|
(57,143
|
)
|
(3,925
|
)
|
6.9
|
%
|
||||||
Underwriting, policy acquisition and operating expenses
|
(14,368
|
)
|
(13,107
|
)
|
(1,261
|
)
|
9.6
|
%
|
|
(28,559
|
)
|
(26,137
|
)
|
(2,422
|
)
|
9.3
|
%
|
||||||
Segment operating results
|
$
|
2,306
|
|
$
|
3,410
|
|
$
|
(1,104
|
)
|
(32.4
|
%)
|
|
$
|
4,339
|
|
$
|
6,107
|
|
$
|
(1,768
|
)
|
(29.0
|
%)
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Net loss ratio
|
65.8%
|
64.8%
|
1.0
|
|
pts
|
|
66.0
|
%
|
65.0
|
%
|
1.0
|
|
pts
|
||||||||||
Underwriting expense ratio
|
30.8%
|
29.0%
|
1.8
|
|
pts
|
|
30.9
|
%
|
29.7
|
%
|
1.2
|
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||||
Gross premiums written
|
$
|
64,218
|
|
$
|
70,885
|
|
$
|
(6,667
|
)
|
(9.4
|
%)
|
|
$
|
153,572
|
|
$
|
162,552
|
|
$
|
(8,980
|
)
|
(5.5
|
%)
|
Less: Ceded premiums written
|
19,187
|
|
21,730
|
|
(2,543
|
)
|
(11.7
|
%)
|
|
57,134
|
|
57,915
|
|
(781
|
)
|
(1.3
|
%)
|
||||||
Net premiums written
|
$
|
45,031
|
|
$
|
49,155
|
|
$
|
(4,124
|
)
|
(8.4
|
%)
|
|
$
|
96,438
|
|
$
|
104,637
|
|
$
|
(8,199
|
)
|
(7.8
|
%)
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Traditional business:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Guaranteed cost
|
$
|
37,559
|
|
|
$
|
39,389
|
|
|
$
|
(1,830
|
)
|
|
(4.6
|
%)
|
|
$
|
80,296
|
|
|
$
|
82,873
|
|
|
$
|
(2,577
|
)
|
|
(3.1
|
%)
|
Policyholder dividend
|
5,068
|
|
|
4,856
|
|
|
212
|
|
|
4.4
|
%
|
|
12,254
|
|
|
13,186
|
|
|
(932
|
)
|
|
(7.1
|
%)
|
||||||
Deductible
|
831
|
|
|
1,873
|
|
|
(1,042
|
)
|
|
(55.6
|
%)
|
|
3,077
|
|
|
4,959
|
|
|
(1,882
|
)
|
|
(38.0
|
%)
|
||||||
Retrospective
|
2,274
|
|
|
3,637
|
|
|
(1,363
|
)
|
|
(37.5
|
%)
|
|
3,037
|
|
|
5,644
|
|
|
(2,607
|
)
|
|
(46.2
|
%)
|
||||||
Other
|
2,775
|
|
|
3,028
|
|
|
(253
|
)
|
|
(8.4
|
%)
|
|
4,602
|
|
|
5,183
|
|
|
(581
|
)
|
|
(11.2
|
%)
|
||||||
Alternative market business
|
15,711
|
|
|
18,102
|
|
|
(2,391
|
)
|
|
(13.2
|
%)
|
|
50,306
|
|
|
50,707
|
|
|
(401
|
)
|
|
(0.8
|
%)
|
||||||
Total
|
$
|
64,218
|
|
|
$
|
70,885
|
|
|
$
|
(6,667
|
)
|
|
(9.4
|
%)
|
|
$
|
153,572
|
|
|
$
|
162,552
|
|
|
$
|
(8,980
|
)
|
|
(5.5
|
%)
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Premiums ceded to SPCs
|
$
|
15,758
|
|
|
$
|
17,717
|
|
|
$
|
(1,959
|
)
|
|
(11.1
|
%)
|
|
$
|
47,903
|
|
|
$
|
46,939
|
|
|
$
|
964
|
|
|
2.1
|
%
|
Premiums ceded to external reinsurers
|
3,373
|
|
|
3,166
|
|
|
207
|
|
|
6.5
|
%
|
|
6,817
|
|
|
6,073
|
|
|
744
|
|
|
12.3
|
%
|
||||||
Premiums ceded to unaffiliated captive insurers
|
(47
|
)
|
|
385
|
|
|
(432
|
)
|
|
(112.2
|
%)
|
|
2,403
|
|
|
3,768
|
|
|
(1,365
|
)
|
|
(36.2
|
%)
|
||||||
Change in return premium estimate under external reinsurance
|
103
|
|
|
462
|
|
|
(359
|
)
|
|
(77.7
|
%)
|
|
11
|
|
|
1,135
|
|
|
(1,124
|
)
|
|
(99.0
|
%)
|
||||||
Total ceded premiums written
|
$
|
19,187
|
|
|
$
|
21,730
|
|
|
$
|
(2,543
|
)
|
|
(11.7
|
%)
|
|
$
|
57,134
|
|
|
$
|
57,915
|
|
|
$
|
(781
|
)
|
|
(1.3
|
%)
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||
Ceded premiums ratio, as reported
|
34.3
|
%
|
|
34.9
|
%
|
|
(0.6
|
)
|
pts
|
|
34.5
|
%
|
|
34.9
|
%
|
|
(0.4
|
)
|
pts
|
Less the effect of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Premiums ceded to SPCs (100%)
|
26.2
|
%
|
|
24.9
|
%
|
|
1.3
|
|
pts
|
|
26.6
|
%
|
|
24.6
|
%
|
|
2.0
|
|
pts
|
Retrospective premium adjustments
|
0.2
|
%
|
|
—
|
%
|
|
0.2
|
|
pts
|
|
0.1
|
%
|
|
—
|
%
|
|
0.1
|
|
pts
|
Premiums ceded to unaffiliated captive insurers (100%)
|
1.1
|
%
|
|
2.7
|
%
|
|
(1.6
|
)
|
pts
|
|
1.0
|
%
|
|
2.8
|
%
|
|
(1.8
|
)
|
pts
|
Return premium estimated under external reinsurance
|
0.2
|
%
|
|
0.9
|
%
|
|
(0.7
|
)
|
pts
|
|
—
|
%
|
|
1.2
|
%
|
|
(1.2
|
)
|
pts
|
Assumed premiums earned (not ceded to external reinsurers)
|
(0.3
|
%)
|
|
(0.3
|
%)
|
|
—
|
|
pts
|
|
(0.3
|
%)
|
|
(0.3
|
%)
|
|
—
|
|
pts
|
Ceded premiums ratio (related to external reinsurance), less the effects of above
|
6.9
|
%
|
|
6.7
|
%
|
|
0.2
|
|
pts
|
|
7.1
|
%
|
|
6.6
|
%
|
|
0.5
|
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||||
Gross premiums earned
|
$
|
70,882
|
|
$
|
69,478
|
|
$
|
1,404
|
|
2.0
|
%
|
|
$
|
141,158
|
|
$
|
135,092
|
|
$
|
6,066
|
|
4.5
|
%
|
Less: Ceded premiums earned
|
24,308
|
|
24,244
|
|
64
|
|
0.3
|
%
|
|
48,646
|
|
47,158
|
|
1,488
|
|
3.2
|
%
|
||||||
Net premiums earned
|
$
|
46,574
|
|
$
|
45,234
|
|
$
|
1,340
|
|
3.0
|
%
|
|
$
|
92,512
|
|
$
|
87,934
|
|
$
|
4,578
|
|
5.2
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||
Calendar year net loss ratio
|
65.8
|
%
|
|
64.8
|
%
|
|
1.0
|
|
pts
|
|
66.0
|
%
|
|
65.0
|
%
|
|
1.0
|
|
pts
|
Less impact of prior accident years on the net loss ratio
|
(2.4
|
%)
|
|
(2.2
|
%)
|
|
(0.2
|
)
|
pts
|
|
(2.2
|
%)
|
|
(1.5
|
%)
|
|
(0.7
|
)
|
pts
|
Current accident year net loss ratio
|
68.2
|
%
|
|
67.0
|
%
|
|
1.2
|
|
pts
|
|
68.2
|
%
|
|
66.5
|
%
|
|
1.7
|
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
DPAC amortization
|
$
|
8,601
|
|
|
$
|
7,503
|
|
|
$
|
1,098
|
|
|
14.6
|
%
|
|
$
|
17,051
|
|
|
$
|
15,375
|
|
|
$
|
1,676
|
|
|
10.9
|
%
|
Management fees
|
482
|
|
|
530
|
|
|
(48
|
)
|
|
(9.1
|
%)
|
|
1,152
|
|
|
1,215
|
|
|
(63
|
)
|
|
(5.2
|
%)
|
||||||
Other underwriting and operating expenses
|
9,798
|
|
|
9,348
|
|
|
450
|
|
|
4.8
|
%
|
|
19,181
|
|
|
18,015
|
|
|
1,166
|
|
|
6.5
|
%
|
||||||
SPC ceding commission offset
|
(4,513
|
)
|
|
(4,274
|
)
|
|
(239
|
)
|
|
5.6
|
%
|
|
(8,825
|
)
|
|
(8,468
|
)
|
|
(357
|
)
|
|
4.2
|
%
|
||||||
Total
|
$
|
14,368
|
|
|
$
|
13,107
|
|
|
$
|
1,261
|
|
|
9.6
|
%
|
|
$
|
28,559
|
|
|
$
|
26,137
|
|
|
$
|
2,422
|
|
|
9.3
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Gross premiums written
|
$
|
16,910
|
|
|
$
|
19,116
|
|
|
$
|
(2,206
|
)
|
|
(11.5
|
%)
|
|
$
|
53,274
|
|
|
$
|
51,456
|
|
|
$
|
1,818
|
|
|
3.5
|
%
|
Less: Ceded premiums written
|
1,973
|
|
|
2,201
|
|
|
(228
|
)
|
|
(10.4
|
%)
|
|
5,656
|
|
|
5,579
|
|
|
77
|
|
|
1.4
|
%
|
||||||
Net premiums written
|
$
|
14,937
|
|
|
$
|
16,915
|
|
|
$
|
(1,978
|
)
|
|
(11.7
|
%)
|
|
$
|
47,618
|
|
|
$
|
45,877
|
|
|
$
|
1,741
|
|
|
3.8
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Workers' compensation
|
$
|
15,758
|
|
|
$
|
17,717
|
|
|
$
|
(1,959
|
)
|
|
(11.1
|
%)
|
|
$
|
47,903
|
|
|
$
|
46,939
|
|
|
$
|
964
|
|
|
2.1
|
%
|
Healthcare professional liability
|
1,152
|
|
|
1,399
|
|
|
(247
|
)
|
|
(17.7
|
%)
|
|
4,890
|
|
|
4,517
|
|
|
373
|
|
|
8.3
|
%
|
||||||
Other
|
—
|
|
|
—
|
|
|
—
|
|
|
nm
|
|
|
481
|
|
|
—
|
|
|
481
|
|
|
nm
|
|
||||||
Gross Premiums Written
|
$
|
16,910
|
|
|
$
|
19,116
|
|
|
$
|
(2,206
|
)
|
|
(11.5
|
%)
|
|
$
|
53,274
|
|
|
$
|
51,456
|
|
|
$
|
1,818
|
|
|
3.5
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||||
Ceded premiums written
|
$
|
1,973
|
|
$
|
2,201
|
|
$
|
(228
|
)
|
(10.4
|
%)
|
|
$
|
5,656
|
|
$
|
5,579
|
|
$
|
77
|
|
1.4
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
|||||||||||
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
|||
Ceded premiums ratio
|
12.5%
|
|
12.4%
|
|
0.1
|
pts
|
|
11.8%
|
|
11.9%
|
|
(0.1
|
)
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||||
Gross premiums earned
|
$
|
21,698
|
|
$
|
20,425
|
|
$
|
1,273
|
|
6.2
|
%
|
|
$
|
43,638
|
|
$
|
39,594
|
|
$
|
4,044
|
|
10.2
|
%
|
Less: Ceded premiums earned
|
2,414
|
|
2,177
|
|
237
|
|
10.9
|
%
|
|
4,851
|
|
4,310
|
|
541
|
|
12.6
|
%
|
||||||
Net premiums earned
|
$
|
19,284
|
|
$
|
18,248
|
|
$
|
1,036
|
|
5.7
|
%
|
|
$
|
38,787
|
|
$
|
35,284
|
|
$
|
3,503
|
|
9.9
|
%
|
|
Three Months Ended June 30
|
||||||||||||||||
|
2019
|
|
2018
|
|
Change
|
||||||||||||
|
As reported
|
|
E&O reserve impact
|
Adjusted
|
|
As reported
|
|
As reported
|
Adjusted
|
||||||||
Calendar year net loss ratio
|
103.6
|
%
|
|
51.6
|
pts
|
52.0
|
%
|
|
49.6
|
%
|
|
54.0
|
|
pts
|
2.4
|
|
pts
|
Less impact of prior accident years on the net loss ratio
|
(11.6
|
%)
|
|
0.2
|
pts
|
(11.8
|
%)
|
|
(16.5
|
%)
|
|
4.9
|
|
pts
|
4.7
|
|
pts
|
Current accident year net loss ratio
|
115.2
|
%
|
|
51.4
|
pts
|
63.8
|
%
|
|
66.1
|
%
|
|
49.1
|
|
pts
|
(2.3
|
)
|
pts
|
|
|||||||||||||||||
|
Six Months Ended June 30
|
||||||||||||||||
|
2019
|
|
2018
|
|
Change
|
||||||||||||
|
As reported
|
|
E&O reserve impact
|
Adjusted
|
|
As reported
|
|
As reported
|
Adjusted
|
||||||||
Calendar year net loss ratio
|
79.2
|
%
|
|
25.5
|
pts
|
53.7
|
%
|
|
53.9
|
%
|
|
25.3
|
|
pts
|
(0.2
|
)
|
pts
|
Less impact of prior accident years on the net loss ratio
|
(11.6
|
%)
|
|
0.2
|
pts
|
(11.8
|
%)
|
|
(12.8
|
%)
|
|
1.2
|
|
pts
|
1.0
|
|
pts
|
Current accident year net loss ratio
|
90.8
|
%
|
|
25.3
|
pts
|
65.5
|
%
|
|
66.7
|
%
|
|
24.1
|
|
pts
|
(1.2
|
)
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
DPAC amortization
|
$
|
5,516
|
|
|
$
|
5,183
|
|
|
$
|
333
|
|
|
6.4
|
%
|
|
$
|
10,666
|
|
|
$
|
10,156
|
|
|
$
|
510
|
|
|
5.0
|
%
|
Other underwriting and operating expenses
|
389
|
|
|
257
|
|
|
132
|
|
|
51.4
|
%
|
|
472
|
|
|
398
|
|
|
74
|
|
|
18.6
|
%
|
||||||
Total
|
$
|
5,905
|
|
|
$
|
5,440
|
|
|
$
|
465
|
|
|
8.5
|
%
|
|
$
|
11,138
|
|
|
$
|
10,554
|
|
|
$
|
584
|
|
|
5.5
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||
Underwriting expense ratio, as reported
|
30.6
|
%
|
|
29.8
|
%
|
|
0.8
|
|
pts
|
|
28.7
|
%
|
|
29.9
|
%
|
|
(1.2
|
)
|
pts
|
Less impact of audit premium on expense ratio
|
(0.8
|
%)
|
|
(0.5
|
%)
|
|
(0.3
|
)
|
pts
|
|
(0.7
|
%)
|
|
(0.3
|
%)
|
|
(0.4
|
)
|
pts
|
Underwriting expense ratio, excluding the effect of audit premium
|
31.4
|
%
|
|
30.3
|
%
|
|
1.1
|
|
pts
|
|
29.4
|
%
|
|
30.2
|
%
|
|
(0.8
|
)
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
||||||||||||||||
Gross premiums written
|
$
|
29,233
|
|
$
|
24,201
|
|
$
|
5,032
|
|
20.8
|
%
|
|
$
|
52,821
|
|
$
|
36,561
|
|
$
|
16,260
|
|
44.5
|
%
|
Ceded premiums written
|
(10,470
|
)
|
(14,335
|
)
|
3,865
|
|
(27.0
|
%)
|
|
(13,061
|
)
|
(14,853
|
)
|
1,792
|
|
(12.1
|
%)
|
||||||
Net premiums written
|
$
|
18,763
|
|
$
|
9,866
|
|
$
|
8,897
|
|
90.2
|
%
|
|
$
|
39,760
|
|
$
|
21,708
|
|
$
|
18,052
|
|
83.2
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Net premiums earned
|
$
|
17,280
|
|
$
|
17,490
|
|
$
|
(210
|
)
|
(1.2
|
%)
|
|
$
|
35,920
|
|
$
|
29,965
|
|
$
|
5,955
|
|
19.9
|
%
|
Net investment income
|
1,199
|
|
836
|
|
363
|
|
43.4
|
%
|
|
2,205
|
|
1,587
|
|
618
|
|
38.9
|
%
|
||||||
Net realized gains (losses)
|
262
|
|
(252
|
)
|
514
|
|
204.0
|
%
|
|
440
|
|
(306
|
)
|
746
|
|
243.8
|
%
|
||||||
Other income (loss)
|
32
|
|
(436
|
)
|
468
|
|
107.3
|
%
|
|
(114
|
)
|
(105
|
)
|
(9
|
)
|
(8.6
|
%)
|
||||||
Net losses and loss adjustment expenses
|
(11,825
|
)
|
(12,505
|
)
|
680
|
|
(5.4
|
%)
|
|
(22,733
|
)
|
(20,991
|
)
|
(1,742
|
)
|
8.3
|
%
|
||||||
Underwriting, policy acquisition and operating expenses
|
(7,564
|
)
|
(8,060
|
)
|
496
|
|
(6.2
|
%)
|
|
(16,033
|
)
|
(15,306
|
)
|
(727
|
)
|
4.7
|
%
|
||||||
Income tax benefit (expense)
|
304
|
|
—
|
|
304
|
|
nm
|
|
|
—
|
|
(6
|
)
|
6
|
|
nm
|
|
||||||
Segment operating results
|
$
|
(312
|
)
|
$
|
(2,927
|
)
|
$
|
2,615
|
|
89.3
|
%
|
|
$
|
(315
|
)
|
$
|
(5,162
|
)
|
$
|
4,847
|
|
93.9
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Net loss ratio
|
68.4%
|
71.5%
|
(3.1
|
)
|
pts
|
|
63.3%
|
70.1%
|
(6.8
|
)
|
pts
|
||||||||||||
Underwriting expense ratio
|
43.8%
|
46.1%
|
(2.3
|
)
|
pts
|
|
44.6%
|
51.1%
|
(6.5
|
)
|
pts
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
|||||||||||||||||||||
($ in thousands)
|
2019
|
2018
|
Change
|
|
2019
|
2018
|
Change
|
|||||||||||||||||
Net investment income
|
$
|
21,972
|
|
$
|
21,175
|
|
$
|
797
|
|
|
3.8
|
%
|
|
$
|
43,337
|
|
$
|
42,095
|
|
$
|
1,242
|
|
3.0
|
%
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
(5,152
|
)
|
$
|
5,380
|
|
$
|
(10,532
|
)
|
|
(195.8
|
%)
|
|
$
|
(5,962
|
)
|
$
|
7,019
|
|
$
|
(12,981
|
)
|
(184.9
|
%)
|
Net realized gains (losses)
|
$
|
9,140
|
|
$
|
3,504
|
|
$
|
5,636
|
|
|
160.8
|
%
|
|
$
|
43,444
|
|
$
|
(8,486
|
)
|
$
|
51,930
|
|
611.9
|
%
|
Other income
|
$
|
833
|
|
$
|
1,095
|
|
$
|
(262
|
)
|
|
(23.9
|
%)
|
|
$
|
1,738
|
|
$
|
2,037
|
|
$
|
(299
|
)
|
(14.7
|
%)
|
Operating expense
|
$
|
5,426
|
|
$
|
5,621
|
|
$
|
(195
|
)
|
|
(3.5
|
%)
|
|
$
|
9,997
|
|
$
|
10,297
|
|
$
|
(300
|
)
|
(2.9
|
%)
|
Interest expense
|
$
|
4,247
|
|
$
|
3,958
|
|
$
|
289
|
|
|
7.3
|
%
|
|
$
|
8,576
|
|
$
|
7,663
|
|
$
|
913
|
|
11.9
|
%
|
Income tax expense (benefit)
|
$
|
27
|
|
$
|
(311
|
)
|
$
|
338
|
|
|
108.7
|
%
|
|
$
|
6,685
|
|
$
|
(3,739
|
)
|
$
|
10,424
|
|
278.8
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Fixed maturities
|
$
|
16,680
|
|
|
$
|
16,225
|
|
|
$
|
455
|
|
|
2.8
|
%
|
|
$
|
32,832
|
|
|
$
|
32,206
|
|
|
$
|
626
|
|
|
1.9
|
%
|
Equities
|
4,990
|
|
|
4,998
|
|
|
(8
|
)
|
|
(0.2
|
%)
|
|
9,813
|
|
|
9,865
|
|
|
(52
|
)
|
|
(0.5
|
%)
|
||||||
Short-term investments, including Other
|
1,449
|
|
|
1,311
|
|
|
138
|
|
|
10.5
|
%
|
|
3,116
|
|
|
2,519
|
|
|
597
|
|
|
23.7
|
%
|
||||||
BOLI
|
459
|
|
|
455
|
|
|
4
|
|
|
0.9
|
%
|
|
912
|
|
|
904
|
|
|
8
|
|
|
0.9
|
%
|
||||||
Investment fees and expenses
|
(1,606
|
)
|
|
(1,814
|
)
|
|
208
|
|
|
(11.5
|
%)
|
|
(3,336
|
)
|
|
(3,399
|
)
|
|
63
|
|
|
(1.9
|
%)
|
||||||
Net investment income
|
$
|
21,972
|
|
|
$
|
21,175
|
|
|
$
|
797
|
|
|
3.8
|
%
|
|
$
|
43,337
|
|
|
$
|
42,095
|
|
|
$
|
1,242
|
|
|
3.0
|
%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
Average income yield
|
3.4%
|
|
3.3%
|
|
3.4%
|
|
3.3%
|
Average tax equivalent income yield
|
3.4%
|
|
3.4%
|
|
3.4%
|
|
3.4%
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
All other investments, primarily investment fund LPs/LLCs
|
$
|
317
|
|
|
$
|
12,497
|
|
|
$
|
(12,180
|
)
|
|
(97.5
|
%)
|
|
$
|
4,126
|
|
|
$
|
20,113
|
|
|
$
|
(15,987
|
)
|
|
(79.5
|
%)
|
Tax credit partnerships
|
(5,469
|
)
|
|
(7,117
|
)
|
|
1,648
|
|
|
(23.2
|
%)
|
|
(10,088
|
)
|
|
(13,094
|
)
|
|
3,006
|
|
|
(23.0
|
%)
|
||||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
(5,152
|
)
|
|
$
|
5,380
|
|
|
$
|
(10,532
|
)
|
|
(195.8
|
%)
|
|
$
|
(5,962
|
)
|
|
$
|
7,019
|
|
|
$
|
(12,981
|
)
|
|
(184.9
|
%)
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
(In millions)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Tax credits recognized during the period
|
$
|
4.7
|
|
|
$
|
5.3
|
|
|
$
|
9.3
|
|
|
$
|
10.6
|
|
Tax benefit of tax credit partnership operating losses
|
$
|
1.1
|
|
|
$
|
1.5
|
|
|
$
|
2.1
|
|
|
$
|
2.7
|
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
GAAP net investment result:
|
|
|
|
|
|
|
|
||||||||
Net investment income
|
$
|
21,972
|
|
|
$
|
21,175
|
|
|
$
|
43,337
|
|
|
$
|
42,095
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
(5,152
|
)
|
|
5,380
|
|
|
(5,962
|
)
|
|
7,019
|
|
||||
GAAP net investment result
|
$
|
16,820
|
|
|
$
|
26,555
|
|
|
$
|
37,375
|
|
|
$
|
49,114
|
|
|
|
|
|
|
|
|
|
||||||||
Pro forma tax-equivalent investment result
|
$
|
23,195
|
|
|
$
|
33,909
|
|
|
$
|
50,097
|
|
|
$
|
64,301
|
|
|
|
|
|
|
|
|
|
||||||||
Reconciliation of pro forma and GAAP tax-equivalent investment result:
|
|
|
|
|
|
|
|
||||||||
GAAP net investment result
|
$
|
16,820
|
|
|
$
|
26,555
|
|
|
$
|
37,375
|
|
|
$
|
49,114
|
|
Taxable equivalent adjustments, calculated using the 21% federal statutory tax rate
|
|
|
|
|
|
|
|
||||||||
State and municipal bonds
|
247
|
|
|
384
|
|
|
467
|
|
|
1,082
|
|
||||
BOLI
|
122
|
|
|
121
|
|
|
242
|
|
|
240
|
|
||||
Dividends received
|
139
|
|
|
119
|
|
|
280
|
|
|
458
|
|
||||
Tax credit partnerships
|
5,867
|
|
|
6,730
|
|
|
11,733
|
|
|
13,407
|
|
||||
Pro forma tax-equivalent investment result
|
$
|
23,195
|
|
|
$
|
33,909
|
|
|
$
|
50,097
|
|
|
$
|
64,301
|
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
OTTI losses, total:
|
|
|
|
|
|
|
|
||||||||
Corporate debt
|
$
|
—
|
|
|
$
|
(404
|
)
|
|
$
|
(136
|
)
|
|
$
|
(404
|
)
|
Portion of OTTI losses recognized in other comprehensive income before taxes:
|
|
|
|
|
|
|
|
||||||||
Corporate debt
|
—
|
|
|
—
|
|
|
87
|
|
|
—
|
|
||||
Net impairment losses recognized in earnings
|
—
|
|
|
(404
|
)
|
|
(49
|
)
|
|
(404
|
)
|
||||
Gross realized gains, available-for-sale fixed maturities
|
966
|
|
|
436
|
|
|
1,226
|
|
|
4,900
|
|
||||
Gross realized (losses), available-for-sale fixed maturities
|
(20
|
)
|
|
(1,693
|
)
|
|
(328
|
)
|
|
(3,728
|
)
|
||||
Net realized gains (losses), equity investments
|
9,179
|
|
|
3,419
|
|
|
10,969
|
|
|
12,519
|
|
||||
Net realized gains (losses), other investments
|
198
|
|
|
402
|
|
|
577
|
|
|
1,090
|
|
||||
Change in unrealized holding gains (losses), equity investments
|
(2,294
|
)
|
|
1,250
|
|
|
27,931
|
|
|
(22,010
|
)
|
||||
Change in unrealized holding gains (losses), convertible securities, carried at fair value as a part of other investments
|
1,110
|
|
|
90
|
|
|
3,116
|
|
|
(864
|
)
|
||||
Other
|
1
|
|
|
4
|
|
|
2
|
|
|
11
|
|
||||
Net realized investment gains (losses)
|
$
|
9,140
|
|
|
$
|
3,504
|
|
|
$
|
43,444
|
|
|
$
|
(8,486
|
)
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
||||||||||||||||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
Change
|
|
2019
|
|
2018
|
|
Change
|
||||||||||||||||||
Operating expenses
|
$
|
8,856
|
|
|
$
|
9,605
|
|
|
$
|
(749
|
)
|
|
(7.8
|
%)
|
|
$
|
18,027
|
|
|
$
|
18,240
|
|
|
$
|
(213
|
)
|
|
(1.2
|
%)
|
Management fee offset
|
(3,430
|
)
|
|
(3,984
|
)
|
|
554
|
|
|
(13.9
|
%)
|
|
(8,030
|
)
|
|
(7,943
|
)
|
|
(87
|
)
|
|
1.1
|
%
|
||||||
Segment Total
|
$
|
5,426
|
|
|
$
|
5,621
|
|
|
$
|
(195
|
)
|
|
(3.5
|
%)
|
|
$
|
9,997
|
|
|
$
|
10,297
|
|
|
$
|
(300
|
)
|
|
(2.9
|
%)
|
|
Three Months Ended
June 30 |
|
Six Months Ended
June 30 |
||||||||||||
(In thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Corporate segment income tax expense (benefit)
|
$
|
27
|
|
|
$
|
(311
|
)
|
|
$
|
6,685
|
|
|
$
|
(3,739
|
)
|
Lloyd's Syndicates segment income tax expense (benefit)
|
(304
|
)
|
|
—
|
|
|
—
|
|
|
6
|
|
||||
Consolidated income tax expense (benefit)
|
$
|
(277
|
)
|
|
$
|
(311
|
)
|
|
$
|
6,685
|
|
|
$
|
(3,733
|
)
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
June 30, 2019
|
||||||||||||||||||
($ in millions)
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
Fair Value:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
$
|
117
|
|
|
$
|
114
|
|
|
$
|
110
|
|
|
$
|
107
|
|
|
$
|
104
|
|
U.S. Government-sponsored enterprise obligations
|
30
|
|
|
29
|
|
|
29
|
|
|
29
|
|
|
28
|
|
|||||
State and municipal bonds
|
311
|
|
|
300
|
|
|
290
|
|
|
280
|
|
|
270
|
|
|||||
Corporate debt
|
1,392
|
|
|
1,349
|
|
|
1,307
|
|
|
1,267
|
|
|
1,228
|
|
|||||
Asset-backed securities
|
514
|
|
|
504
|
|
|
493
|
|
|
480
|
|
|
467
|
|
|||||
Total fixed maturities, available for sale
|
$
|
2,364
|
|
|
$
|
2,296
|
|
|
$
|
2,229
|
|
|
$
|
2,163
|
|
|
$
|
2,097
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
3.09
|
|
|
3.01
|
|
|
2.93
|
|
|
2.86
|
|
|
2.79
|
|
|||||
U.S. Government-sponsored enterprise obligations
|
0.66
|
|
|
0.60
|
|
|
1.16
|
|
|
2.97
|
|
|
3.86
|
|
|||||
State and municipal bonds
|
3.46
|
|
|
3.41
|
|
|
3.43
|
|
|
3.52
|
|
|
3.61
|
|
|||||
Corporate debt
|
3.09
|
|
|
3.04
|
|
|
3.02
|
|
|
3.01
|
|
|
2.97
|
|
|||||
Asset-backed securities
|
2.06
|
|
|
2.18
|
|
|
2.46
|
|
|
2.77
|
|
|
2.90
|
|
|||||
Total fixed maturities, available for sale
|
2.88
|
|
|
2.87
|
|
|
2.92
|
|
|
3.01
|
|
|
3.04
|
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
December 31, 2018
|
||||||||||||||||||
($ in millions)
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
Fair Value:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
$
|
127
|
|
|
$
|
124
|
|
|
$
|
120
|
|
|
$
|
117
|
|
|
$
|
114
|
|
U.S. Government-sponsored enterprise obligations
|
36
|
|
|
36
|
|
|
35
|
|
|
34
|
|
|
33
|
|
|||||
State and municipal bonds
|
316
|
|
|
305
|
|
|
294
|
|
|
283
|
|
|
273
|
|
|||||
Corporate debt
|
1,300
|
|
|
1,261
|
|
|
1,224
|
|
|
1,187
|
|
|
1,153
|
|
|||||
Asset-backed securities
|
443
|
|
|
432
|
|
|
421
|
|
|
409
|
|
|
396
|
|
|||||
Total fixed maturities, available for sale
|
$
|
2,222
|
|
|
$
|
2,158
|
|
|
$
|
2,094
|
|
|
$
|
2,030
|
|
|
$
|
1,969
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
2.77
|
|
|
2.70
|
|
|
2.63
|
|
|
2.57
|
|
|
2.50
|
|
|||||
U.S. Government-sponsored enterprise obligations
|
0.66
|
|
|
0.98
|
|
|
2.65
|
|
|
3.77
|
|
|
4.18
|
|
|||||
State and municipal bonds
|
3.61
|
|
|
3.58
|
|
|
3.59
|
|
|
3.64
|
|
|
3.73
|
|
|||||
Corporate debt
|
2.98
|
|
|
2.97
|
|
|
2.93
|
|
|
2.89
|
|
|
2.83
|
|
|||||
Asset-backed securities
|
2.18
|
|
|
2.46
|
|
|
2.86
|
|
|
3.11
|
|
|
3.23
|
|
|||||
Total fixed maturities, available for sale
|
2.86
|
|
|
2.91
|
|
|
2.99
|
|
|
3.04
|
|
|
3.04
|
|
(a)
|
Not applicable.
|
(b)
|
Not applicable.
|
(c)
|
Information required by Item 703 of Regulation S-K.
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs* (In thousands)
|
||
April 1 - 30, 2019
|
|
—
|
|
|
N/A
|
|
—
|
|
|
$109,643
|
May 1 - 31, 2019
|
|
—
|
|
|
N/A
|
|
—
|
|
|
$109,643
|
June 1 - 30, 2019
|
|
—
|
|
|
N/A
|
|
—
|
|
|
$109,643
|
Total
|
|
—
|
|
|
$—
|
|
—
|
|
|
|
*
|
Under its current plan begun in November 2010, the Board has authorized $600 million for the repurchase of common shares or the retirement of outstanding debt. This is ProAssurance’s only plan for the repurchase of common shares, and the plan has no expiration date.
|
Exhibit Number
|
|
Description
|
|
|
|
|
|
|
|
Employment Agreement between ProAssurance and Michael Boguski dated as of May 1, 2019.
|
|
|
|
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC rule 13a-14(a).
|
|
|
|
|
|
Certification of Principal Financial and Accounting Officer of ProAssurance as required under SEC rule 13a-14(a).
|
|
|
|
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as amended (18 U.S.C. 1350).
|
|
|
|
|
|
Certification of Principal Financial and Accounting Officer of ProAssurance as required under SEC Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as amended (18 U.S.C. 1350).
|
|
|
|
|
|
XBRL Instance Document
|
|
|
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
PROASSURANCE CORPORATION
|
/s/ Dana S. Hendricks
|
Dana S. Hendricks
|
Chief Financial Officer
|
(Duly authorized officer and principal financial officer)
|
|
/s/ Edward L. Rand, Jr.
|
Edward L. Rand, Jr.
|
Chief Executive Officer and
principal executive officer
|
|
/s/ Dana S. Hendricks
|
Dana S. Hendricks
|
Chief Financial Officer and
principal financial officer
|
|
/s/ Edward L. Rand, Jr.
|
Edward L. Rand, Jr.
|
Chief Executive Officer and
principal executive officer
|
|
/s/ Dana S. Hendricks
|
Dana S. Hendricks
|
Chief Financial Officer, and
principal financial officer
|